{
    "medicine_id": "01d05b8454c82381db7636a4cb753d1c47f486d6",
    "platform_id": "DB13345",
    "metadata": {
        "name": "Ergoloid Mesylates 500 mcg Tablet coated",
        "composition": "500 mcg Dihydroergocristine",
        "clinical_particulars": {
            "therapeutic_indications": "Dihydroergocristine is used in some countries such as Brasil as a single agent for the treatment of cerebral and peripheric vascular events L2649 To know more about dihydroergocristine as part of the ergoloid mesylate mixture please visit DB01049",
            "contraindications": {
                "disease": "Studies related to acute and chronic toxicity as well as teratogenesis and fertility has proven that dihydroergocristine is a non toxic and very well tolerated drug A32880 To know more about dihydroergocristine as part of the ergoloid mesylate mixture please visit DB01049",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "Dihydroergocristine has been shown to present effect on memory and cognition This activity in the brain is been reported by an increase in glutathione in age related brain states A32880 The reported effect on serotonin and adrenergic receptors has also been correlated to an inhibition of platelet aggregation L2649 It has also been reported that individuals exposed to dihydroergocristine may present an amphoteric vasoregulating activity either hypotensive in hypertensive individuals or hypertensive in hypotensive individuals A32879 This action is performed by promoting a dilating action in the contracted arteries and a tonic action in the dilated arteries and arterioles L2649 The vasoregulating effect causes an increase in cerebral blood flow and oxygen consumption by the brain which correlates with the brain protective function of dihydroergocristine A32880 In Alzheimer studies dihydroergocristine reduced the amyloid beta levels in different cell types A32882 To know more about dihydroergocristine as part of the ergoloid mesylate mixture please visit DB01049",
                "excipients": "NA",
                "incompatibilities": [
                    {
                        "drugbank-id": "DB00197",
                        "description": "Troglitazone may decrease the excretion rate of Dihydroergocristine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00206",
                        "description": "Reserpine may decrease the excretion rate of Dihydroergocristine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00396",
                        "description": "Progesterone may decrease the excretion rate of Dihydroergocristine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00477",
                        "description": "Chlorpromazine may decrease the excretion rate of Dihydroergocristine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00482",
                        "description": "Celecoxib may decrease the excretion rate of Dihydroergocristine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00501",
                        "description": "Cimetidine may decrease the excretion rate of Dihydroergocristine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00559",
                        "description": "Bosentan may decrease the excretion rate of Dihydroergocristine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00977",
                        "description": "Ethinylestradiol may decrease the excretion rate of Dihydroergocristine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01016",
                        "description": "Glyburide may decrease the excretion rate of Dihydroergocristine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01586",
                        "description": "Ursodeoxycholic acid may decrease the excretion rate of Dihydroergocristine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB02659",
                        "description": "Cholic Acid may decrease the excretion rate of Dihydroergocristine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB02703",
                        "description": "Fusidic acid may decrease the excretion rate of Dihydroergocristine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06290",
                        "description": "Simeprevir may decrease the excretion rate of Dihydroergocristine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09078",
                        "description": "Lenvatinib may decrease the excretion rate of Dihydroergocristine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB12070",
                        "description": "Letermovir may decrease the excretion rate of Dihydroergocristine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB14057",
                        "description": "Valinomycin may decrease the excretion rate of Dihydroergocristine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00275",
                        "description": "Olmesartan may decrease the excretion rate of Dihydroergocristine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB15822",
                        "description": "Pralsetinib may decrease the excretion rate of Dihydroergocristine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00252",
                        "description": "The metabolism of Dihydroergocristine can be increased when combined with Phenytoin"
                    },
                    {
                        "drugbank-id": "DB01320",
                        "description": "The metabolism of Dihydroergocristine can be increased when combined with Fosphenytoin"
                    },
                    {
                        "drugbank-id": "DB00177",
                        "description": "Dihydroergocristine may decrease the antihypertensive activities of Valsartan"
                    },
                    {
                        "drugbank-id": "DB00178",
                        "description": "Dihydroergocristine may decrease the antihypertensive activities of Ramipril"
                    },
                    {
                        "drugbank-id": "DB00212",
                        "description": "Dihydroergocristine may decrease the antihypertensive activities of Remikiren"
                    },
                    {
                        "drugbank-id": "DB00214",
                        "description": "Dihydroergocristine may decrease the antihypertensive activities of Torasemide"
                    },
                    {
                        "drugbank-id": "DB00226",
                        "description": "Dihydroergocristine may decrease the antihypertensive activities of Guanadrel"
                    },
                    {
                        "drugbank-id": "DB00310",
                        "description": "Dihydroergocristine may decrease the antihypertensive activities of Chlorthalidone"
                    },
                    {
                        "drugbank-id": "DB00325",
                        "description": "Dihydroergocristine may decrease the antihypertensive activities of Nitroprusside"
                    },
                    {
                        "drugbank-id": "DB00350",
                        "description": "Dihydroergocristine may decrease the antihypertensive activities of Minoxidil"
                    },
                    {
                        "drugbank-id": "DB00374",
                        "description": "Dihydroergocristine may decrease the antihypertensive activities of Treprostinil"
                    },
                    {
                        "drugbank-id": "DB00436",
                        "description": "Dihydroergocristine may decrease the antihypertensive activities of Bendroflumethiazide"
                    },
                    {
                        "drugbank-id": "DB00457",
                        "description": "Dihydroergocristine may decrease the antihypertensive activities of Prazosin"
                    },
                    {
                        "drugbank-id": "DB00492",
                        "description": "Dihydroergocristine may decrease the antihypertensive activities of Fosinopril"
                    },
                    {
                        "drugbank-id": "DB00519",
                        "description": "Dihydroergocristine may decrease the antihypertensive activities of Trandolapril"
                    },
                    {
                        "drugbank-id": "DB00524",
                        "description": "Dihydroergocristine may decrease the antihypertensive activities of Metolazone"
                    },
                    {
                        "drugbank-id": "DB00542",
                        "description": "Dihydroergocristine may decrease the antihypertensive activities of Benazepril"
                    },
                    {
                        "drugbank-id": "DB00606",
                        "description": "Dihydroergocristine may decrease the antihypertensive activities of Cyclothiazide"
                    },
                    {
                        "drugbank-id": "DB00616",
                        "description": "Dihydroergocristine may decrease the antihypertensive activities of Candoxatril"
                    },
                    {
                        "drugbank-id": "DB00657",
                        "description": "Dihydroergocristine may decrease the antihypertensive activities of Mecamylamine"
                    },
                    {
                        "drugbank-id": "DB00691",
                        "description": "Dihydroergocristine may decrease the antihypertensive activities of Moexipril"
                    },
                    {
                        "drugbank-id": "DB00722",
                        "description": "Dihydroergocristine may decrease the antihypertensive activities of Lisinopril"
                    },
                    {
                        "drugbank-id": "DB00765",
                        "description": "Dihydroergocristine may decrease the antihypertensive activities of Metyrosine"
                    },
                    {
                        "drugbank-id": "DB00774",
                        "description": "Dihydroergocristine may decrease the antihypertensive activities of Hydroflumethiazide"
                    },
                    {
                        "drugbank-id": "DB00785",
                        "description": "Dihydroergocristine may decrease the antihypertensive activities of Cryptenamine"
                    },
                    {
                        "drugbank-id": "DB00790",
                        "description": "Dihydroergocristine may decrease the antihypertensive activities of Perindopril"
                    },
                    {
                        "drugbank-id": "DB00796",
                        "description": "Dihydroergocristine may decrease the antihypertensive activities of Candesartan cilexetil"
                    },
                    {
                        "drugbank-id": "DB00800",
                        "description": "Dihydroergocristine may decrease the antihypertensive activities of Fenoldopam"
                    },
                    {
                        "drugbank-id": "DB00876",
                        "description": "Dihydroergocristine may decrease the antihypertensive activities of Eprosartan"
                    },
                    {
                        "drugbank-id": "DB00880",
                        "description": "Dihydroergocristine may decrease the antihypertensive activities of Chlorothiazide"
                    },
                    {
                        "drugbank-id": "DB00881",
                        "description": "Dihydroergocristine may decrease the antihypertensive activities of Quinapril"
                    },
                    {
                        "drugbank-id": "DB00999",
                        "description": "Dihydroergocristine may decrease the antihypertensive activities of Hydrochlorothiazide"
                    },
                    {
                        "drugbank-id": "DB01021",
                        "description": "Dihydroergocristine may decrease the antihypertensive activities of Trichlormethiazide"
                    },
                    {
                        "drugbank-id": "DB01089",
                        "description": "Dihydroergocristine may decrease the antihypertensive activities of Deserpidine"
                    },
                    {
                        "drugbank-id": "DB01090",
                        "description": "Dihydroergocristine may decrease the antihypertensive activities of Pentolinium"
                    },
                    {
                        "drugbank-id": "DB01116",
                        "description": "Dihydroergocristine may decrease the antihypertensive activities of Trimethaphan"
                    },
                    {
                        "drugbank-id": "DB01119",
                        "description": "Dihydroergocristine may decrease the antihypertensive activities of Diazoxide"
                    },
                    {
                        "drugbank-id": "DB01158",
                        "description": "Dihydroergocristine may decrease the antihypertensive activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB01162",
                        "description": "Dihydroergocristine may decrease the antihypertensive activities of Terazosin"
                    },
                    {
                        "drugbank-id": "DB01197",
                        "description": "Dihydroergocristine may decrease the antihypertensive activities of Captopril"
                    },
                    {
                        "drugbank-id": "DB01240",
                        "description": "Dihydroergocristine may decrease the antihypertensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB01324",
                        "description": "Dihydroergocristine may decrease the antihypertensive activities of Polythiazide"
                    },
                    {
                        "drugbank-id": "DB01340",
                        "description": "Dihydroergocristine may decrease the antihypertensive activities of Cilazapril"
                    },
                    {
                        "drugbank-id": "DB01347",
                        "description": "Dihydroergocristine may decrease the antihypertensive activities of Saprisartan"
                    },
                    {
                        "drugbank-id": "DB01348",
                        "description": "Dihydroergocristine may decrease the antihypertensive activities of Spirapril"
                    },
                    {
                        "drugbank-id": "DB04831",
                        "description": "Dihydroergocristine may decrease the antihypertensive activities of Tienilic acid"
                    },
                    {
                        "drugbank-id": "DB04840",
                        "description": "Dihydroergocristine may decrease the antihypertensive activities of Debrisoquine"
                    },
                    {
                        "drugbank-id": "DB06445",
                        "description": "Dihydroergocristine may decrease the antihypertensive activities of Diethylnorspermine"
                    },
                    {
                        "drugbank-id": "DB07767",
                        "description": "Dihydroergocristine may decrease the antihypertensive activities of Ferulic acid"
                    },
                    {
                        "drugbank-id": "DB08836",
                        "description": "Dihydroergocristine may decrease the antihypertensive activities of Temocapril"
                    },
                    {
                        "drugbank-id": "DB08960",
                        "description": "Dihydroergocristine may decrease the antihypertensive activities of Hexamethonium"
                    },
                    {
                        "drugbank-id": "DB09206",
                        "description": "Dihydroergocristine may decrease the antihypertensive activities of Trimazosin"
                    },
                    {
                        "drugbank-id": "DB09220",
                        "description": "Dihydroergocristine may decrease the antihypertensive activities of Nicorandil"
                    },
                    {
                        "drugbank-id": "DB09363",
                        "description": "Dihydroergocristine may decrease the antihypertensive activities of Rauwolfia serpentina root"
                    },
                    {
                        "drugbank-id": "DB09477",
                        "description": "Dihydroergocristine may decrease the antihypertensive activities of Enalaprilat"
                    },
                    {
                        "drugbank-id": "DB11720",
                        "description": "Dihydroergocristine may decrease the antihypertensive activities of Angiotensin 1 7"
                    },
                    {
                        "drugbank-id": "DB11783",
                        "description": "Dihydroergocristine may decrease the antihypertensive activities of Imidapril"
                    },
                    {
                        "drugbank-id": "DB12054",
                        "description": "Dihydroergocristine may decrease the antihypertensive activities of BQ 123"
                    },
                    {
                        "drugbank-id": "DB12465",
                        "description": "Dihydroergocristine may decrease the antihypertensive activities of Ketanserin"
                    },
                    {
                        "drugbank-id": "DB12766",
                        "description": "Dihydroergocristine may decrease the antihypertensive activities of Cicletanine"
                    },
                    {
                        "drugbank-id": "DB12945",
                        "description": "Dihydroergocristine may decrease the antihypertensive activities of Dihydralazine"
                    },
                    {
                        "drugbank-id": "DB13166",
                        "description": "Dihydroergocristine may decrease the antihypertensive activities of Zofenopril"
                    },
                    {
                        "drugbank-id": "DB13211",
                        "description": "Dihydroergocristine may decrease the antihypertensive activities of Guanoxan"
                    },
                    {
                        "drugbank-id": "DB13312",
                        "description": "Dihydroergocristine may decrease the antihypertensive activities of Delapril"
                    },
                    {
                        "drugbank-id": "DB13374",
                        "description": "Dihydroergocristine may decrease the antihypertensive activities of Vincamine"
                    },
                    {
                        "drugbank-id": "DB13400",
                        "description": "Dihydroergocristine may decrease the antihypertensive activities of Linsidomine"
                    },
                    {
                        "drugbank-id": "DB13410",
                        "description": "Dihydroergocristine may decrease the antihypertensive activities of Guanoxabenz"
                    },
                    {
                        "drugbank-id": "DB13429",
                        "description": "Dihydroergocristine may decrease the antihypertensive activities of Tolonidine"
                    },
                    {
                        "drugbank-id": "DB13435",
                        "description": "Dihydroergocristine may decrease the antihypertensive activities of Endralazine"
                    },
                    {
                        "drugbank-id": "DB13452",
                        "description": "Dihydroergocristine may decrease the antihypertensive activities of Cadralazine"
                    },
                    {
                        "drugbank-id": "DB13532",
                        "description": "Dihydroergocristine may decrease the antihypertensive activities of Cyclopenthiazide"
                    },
                    {
                        "drugbank-id": "DB13575",
                        "description": "Dihydroergocristine may decrease the antihypertensive activities of Bietaserpine"
                    },
                    {
                        "drugbank-id": "DB13604",
                        "description": "Dihydroergocristine may decrease the antihypertensive activities of Guanazodine"
                    },
                    {
                        "drugbank-id": "DB13631",
                        "description": "Dihydroergocristine may decrease the antihypertensive activities of Methoserpidine"
                    },
                    {
                        "drugbank-id": "DB13779",
                        "description": "Dihydroergocristine may decrease the antihypertensive activities of Guanoclor"
                    },
                    {
                        "drugbank-id": "DB13801",
                        "description": "Dihydroergocristine may decrease the antihypertensive activities of Muzolimine"
                    },
                    {
                        "drugbank-id": "DB13803",
                        "description": "Dihydroergocristine may decrease the antihypertensive activities of Xipamide"
                    },
                    {
                        "drugbank-id": "DB13919",
                        "description": "Dihydroergocristine may decrease the antihypertensive activities of Candesartan"
                    },
                    {
                        "drugbank-id": "DB14094",
                        "description": "Dihydroergocristine may decrease the antihypertensive activities of Tocopherylquinone"
                    },
                    {
                        "drugbank-id": "DB14125",
                        "description": "Dihydroergocristine may decrease the antihypertensive activities of Benazeprilat"
                    },
                    {
                        "drugbank-id": "DB14207",
                        "description": "Dihydroergocristine may decrease the antihypertensive activities of Fosinoprilat"
                    },
                    {
                        "drugbank-id": "DB14208",
                        "description": "Dihydroergocristine may decrease the antihypertensive activities of Ramiprilat"
                    },
                    {
                        "drugbank-id": "DB14213",
                        "description": "Dihydroergocristine may decrease the antihypertensive activities of Perindoprilat"
                    },
                    {
                        "drugbank-id": "DB14217",
                        "description": "Dihydroergocristine may decrease the antihypertensive activities of Quinaprilat"
                    },
                    {
                        "drugbank-id": "DB00695",
                        "description": "Dihydroergocristine may decrease the antihypertensive activities of Furosemide"
                    },
                    {
                        "drugbank-id": "DB00584",
                        "description": "Dihydroergocristine may decrease the antihypertensive activities of Enalapril"
                    },
                    {
                        "drugbank-id": "DB00381",
                        "description": "Dihydroergocristine may decrease the antihypertensive activities of Amlodipine"
                    },
                    {
                        "drugbank-id": "DB00393",
                        "description": "Dihydroergocristine may decrease the antihypertensive activities of Nimodipine"
                    },
                    {
                        "drugbank-id": "DB00528",
                        "description": "Dihydroergocristine may decrease the antihypertensive activities of Lercanidipine"
                    },
                    {
                        "drugbank-id": "DB00808",
                        "description": "Dihydroergocristine may decrease the antihypertensive activities of Indapamide"
                    },
                    {
                        "drugbank-id": "DB01170",
                        "description": "Dihydroergocristine may decrease the antihypertensive activities of Guanethidine"
                    },
                    {
                        "drugbank-id": "DB01244",
                        "description": "Dihydroergocristine may decrease the antihypertensive activities of Bepridil"
                    },
                    {
                        "drugbank-id": "DB06403",
                        "description": "Dihydroergocristine may decrease the antihypertensive activities of Ambrisentan"
                    },
                    {
                        "drugbank-id": "DB06762",
                        "description": "Dihydroergocristine may decrease the antihypertensive activities of Pinacidil"
                    },
                    {
                        "drugbank-id": "DB08931",
                        "description": "Dihydroergocristine may decrease the antihypertensive activities of Riociguat"
                    },
                    {
                        "drugbank-id": "DB08932",
                        "description": "Dihydroergocristine may decrease the antihypertensive activities of Macitentan"
                    },
                    {
                        "drugbank-id": "DB09026",
                        "description": "Dihydroergocristine may decrease the antihypertensive activities of Aliskiren"
                    },
                    {
                        "drugbank-id": "DB09236",
                        "description": "Dihydroergocristine may decrease the antihypertensive activities of Lacidipine"
                    },
                    {
                        "drugbank-id": "DB09239",
                        "description": "Dihydroergocristine may decrease the antihypertensive activities of Niguldipine"
                    },
                    {
                        "drugbank-id": "DB11362",
                        "description": "Dihydroergocristine may decrease the antihypertensive activities of Selexipag"
                    },
                    {
                        "drugbank-id": "DB12092",
                        "description": "Dihydroergocristine may decrease the antihypertensive activities of Naftopidil"
                    },
                    {
                        "drugbank-id": "DB12093",
                        "description": "Dihydroergocristine may decrease the antihypertensive activities of Tetrahydropalmatine"
                    },
                    {
                        "drugbank-id": "DB14068",
                        "description": "Dihydroergocristine may decrease the antihypertensive activities of Dexniguldipine"
                    },
                    {
                        "drugbank-id": "DB00820",
                        "description": "Dihydroergocristine may decrease the antihypertensive activities of Tadalafil"
                    },
                    {
                        "drugbank-id": "DB00401",
                        "description": "Dihydroergocristine may decrease the antihypertensive activities of Nisoldipine"
                    },
                    {
                        "drugbank-id": "DB00700",
                        "description": "Dihydroergocristine may decrease the antihypertensive activities of Eplerenone"
                    },
                    {
                        "drugbank-id": "DB09237",
                        "description": "Dihydroergocristine may decrease the antihypertensive activities of Levamlodipine"
                    },
                    {
                        "drugbank-id": "DB00035",
                        "description": "The risk or severity of hypertension can be increased when Desmopressin is combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB00159",
                        "description": "The risk or severity of hypertension can be increased when Icosapent is combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB00244",
                        "description": "The risk or severity of hypertension can be increased when Mesalazine is combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB00289",
                        "description": "The risk or severity of hypertension can be increased when Atomoxetine is combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB00344",
                        "description": "The risk or severity of hypertension can be increased when Protriptyline is combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB00422",
                        "description": "The risk or severity of hypertension can be increased when Methylphenidate is combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB00450",
                        "description": "The risk or severity of hypertension can be increased when Droperidol is combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB00461",
                        "description": "The risk or severity of hypertension can be increased when Nabumetone is combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB00465",
                        "description": "The risk or severity of hypertension can be increased when Ketorolac is combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB00469",
                        "description": "The risk or severity of hypertension can be increased when Tenoxicam is combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB00500",
                        "description": "The risk or severity of hypertension can be increased when Tolmetin is combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB00543",
                        "description": "The risk or severity of hypertension can be increased when Amoxapine is combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB00554",
                        "description": "The risk or severity of hypertension can be increased when Piroxicam is combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB00561",
                        "description": "The risk or severity of hypertension can be increased when Doxapram is combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB00573",
                        "description": "The risk or severity of hypertension can be increased when Fenoprofen is combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB00601",
                        "description": "The risk or severity of hypertension can be increased when Linezolid is combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB00605",
                        "description": "The risk or severity of hypertension can be increased when Sulindac is combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB00614",
                        "description": "The risk or severity of hypertension can be increased when Furazolidone is combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB00679",
                        "description": "The risk or severity of hypertension can be increased when Thioridazine is combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB00692",
                        "description": "The risk or severity of hypertension can be increased when Phentolamine is combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB00699",
                        "description": "The risk or severity of hypertension can be increased when Nicergoline is combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB00712",
                        "description": "The risk or severity of hypertension can be increased when Flurbiprofen is combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB00749",
                        "description": "The risk or severity of hypertension can be increased when Etodolac is combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB00753",
                        "description": "The risk or severity of hypertension can be increased when Isoflurane is combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB00777",
                        "description": "The risk or severity of hypertension can be increased when Propiomazine is combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB00784",
                        "description": "The risk or severity of hypertension can be increased when Mefenamic acid is combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB00795",
                        "description": "The risk or severity of hypertension can be increased when Sulfasalazine is combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB00797",
                        "description": "The risk or severity of hypertension can be increased when Tolazoline is combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB00805",
                        "description": "The risk or severity of hypertension can be increased when Minaprine is combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB00818",
                        "description": "The risk or severity of hypertension can be increased when Propofol is combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB00821",
                        "description": "The risk or severity of hypertension can be increased when Carprofen is combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB00830",
                        "description": "The risk or severity of hypertension can be increased when Phenmetrazine is combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB00831",
                        "description": "The risk or severity of hypertension can be increased when Trifluoperazine is combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB00861",
                        "description": "The risk or severity of hypertension can be increased when Diflunisal is combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB00875",
                        "description": "The risk or severity of hypertension can be increased when Flupentixol is combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB00886",
                        "description": "The risk or severity of hypertension can be increased when Omapatrilat is combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB00899",
                        "description": "The risk or severity of hypertension can be increased when Remifentanil is combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB00925",
                        "description": "The risk or severity of hypertension can be increased when Phenoxybenzamine is combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB00936",
                        "description": "The risk or severity of hypertension can be increased when Salicylic acid is combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB00939",
                        "description": "The risk or severity of hypertension can be increased when Meclofenamic acid is combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB00945",
                        "description": "The risk or severity of hypertension can be increased when Acetylsalicylic acid is combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB00988",
                        "description": "The risk or severity of hypertension can be increased when Dopamine is combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB00991",
                        "description": "The risk or severity of hypertension can be increased when Oxaprozin is combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB01009",
                        "description": "The risk or severity of hypertension can be increased when Ketoprofen is combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB01014",
                        "description": "The risk or severity of hypertension can be increased when Balsalazide is combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB01171",
                        "description": "The risk or severity of hypertension can be increased when Moclobemide is combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB01180",
                        "description": "The risk or severity of hypertension can be increased when Rescinnamine is combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB01189",
                        "description": "The risk or severity of hypertension can be increased when Desflurane is combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB01247",
                        "description": "The risk or severity of hypertension can be increased when Isocarboxazid is combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB01250",
                        "description": "The risk or severity of hypertension can be increased when Olsalazine is combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB01283",
                        "description": "The risk or severity of hypertension can be increased when Lumiracoxib is combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB01367",
                        "description": "The risk or severity of hypertension can be increased when Rasagiline is combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB01397",
                        "description": "The risk or severity of hypertension can be increased when Magnesium salicylate is combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB01399",
                        "description": "The risk or severity of hypertension can be increased when Salsalate is combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB01401",
                        "description": "The risk or severity of hypertension can be increased when Choline magnesium trisalicylate is combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB01403",
                        "description": "The risk or severity of hypertension can be increased when Methotrimeprazine is combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB01419",
                        "description": "The risk or severity of hypertension can be increased when Antrafenine is combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB01600",
                        "description": "The risk or severity of hypertension can be increased when Tiaprofenic acid is combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB01608",
                        "description": "The risk or severity of hypertension can be increased when Periciazine is combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB01614",
                        "description": "The risk or severity of hypertension can be increased when Acepromazine is combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB01622",
                        "description": "The risk or severity of hypertension can be increased when Thioproperazine is combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB01626",
                        "description": "The risk or severity of hypertension can be increased when Pargyline is combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB02032",
                        "description": "The risk or severity of hypertension can be increased when Epicaptopril is combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB02224",
                        "description": "The risk or severity of hypertension can be increased when Taxifolin is combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB03585",
                        "description": "The risk or severity of hypertension can be increased when Oxyphenbutazone is combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB04017",
                        "description": "The risk or severity of hypertension can be increased when Clorgiline is combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB04581",
                        "description": "The risk or severity of hypertension can be increased when 1 benzylimidazole is combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB04812",
                        "description": "The risk or severity of hypertension can be increased when Benoxaprofen is combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB04818",
                        "description": "The risk or severity of hypertension can be increased when Iproniazid is combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB04820",
                        "description": "The risk or severity of hypertension can be increased when Nialamide is combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB04836",
                        "description": "The risk or severity of hypertension can be increased when Amineptine is combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB05095",
                        "description": "The risk or severity of hypertension can be increased when Cimicoxib is combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB06153",
                        "description": "The risk or severity of hypertension can be increased when Pizotifen is combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB06678",
                        "description": "The risk or severity of hypertension can be increased when Esmirtazapine is combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB06690",
                        "description": "The risk or severity of hypertension can be increased when Nitrous oxide is combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB06701",
                        "description": "The risk or severity of hypertension can be increased when Dexmethylphenidate is combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB06725",
                        "description": "The risk or severity of hypertension can be increased when Lornoxicam is combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB06736",
                        "description": "The risk or severity of hypertension can be increased when Aceclofenac is combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB06737",
                        "description": "The risk or severity of hypertension can be increased when Zaltoprofen is combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB06763",
                        "description": "The risk or severity of hypertension can be increased when Saralasin is combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB07402",
                        "description": "The risk or severity of hypertension can be increased when Azapropazone is combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB08797",
                        "description": "The risk or severity of hypertension can be increased when Salicylamide is combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB08841",
                        "description": "The risk or severity of hypertension can be increased when Tyramine is combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB08940",
                        "description": "The risk or severity of hypertension can be increased when Kebuzone is combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB08942",
                        "description": "The risk or severity of hypertension can be increased when Isoxicam is combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB08950",
                        "description": "The risk or severity of hypertension can be increased when Indoramin is combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB08951",
                        "description": "The risk or severity of hypertension can be increased when Indoprofen is combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB08954",
                        "description": "The risk or severity of hypertension can be increased when Ifenprodil is combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB08955",
                        "description": "The risk or severity of hypertension can be increased when Ibuproxam is combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB08976",
                        "description": "The risk or severity of hypertension can be increased when Floctafenine is combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB08981",
                        "description": "The risk or severity of hypertension can be increased when Fenbufen is combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB08984",
                        "description": "The risk or severity of hypertension can be increased when Etofenamate is combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB08991",
                        "description": "The risk or severity of hypertension can be increased when Epirizole is combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB08996",
                        "description": "The risk or severity of hypertension can be increased when Dimetacrine is combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB09016",
                        "description": "The risk or severity of hypertension can be increased when Butriptyline is combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB09084",
                        "description": "The risk or severity of hypertension can be increased when Benzydamine is combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB09167",
                        "description": "The risk or severity of hypertension can be increased when Dosulepin is combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB09205",
                        "description": "The risk or severity of hypertension can be increased when Moxisylyte is combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB09213",
                        "description": "The risk or severity of hypertension can be increased when Dexibuprofen is combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB09214",
                        "description": "The risk or severity of hypertension can be increased when Dexketoprofen is combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB09215",
                        "description": "The risk or severity of hypertension can be increased when Droxicam is combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB09217",
                        "description": "The risk or severity of hypertension can be increased when Firocoxib is combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB09218",
                        "description": "The risk or severity of hypertension can be increased when Clonixin is combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB09243",
                        "description": "The risk or severity of hypertension can be increased when Hydracarbazine is combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB09244",
                        "description": "The risk or severity of hypertension can be increased when Pirlindole is combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB09245",
                        "description": "The risk or severity of hypertension can be increased when Toloxatone is combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB09246",
                        "description": "The risk or severity of hypertension can be increased when Benmoxin is combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB09248",
                        "description": "The risk or severity of hypertension can be increased when Mebanazine is combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB09249",
                        "description": "The risk or severity of hypertension can be increased when Octamoxin is combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB09250",
                        "description": "The risk or severity of hypertension can be increased when Pheniprazine is combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB09251",
                        "description": "The risk or severity of hypertension can be increased when Phenoxypropazine is combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB09252",
                        "description": "The risk or severity of hypertension can be increased when Pivhydrazine is combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB09253",
                        "description": "The risk or severity of hypertension can be increased when Safrazine is combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB09254",
                        "description": "The risk or severity of hypertension can be increased when Caroxazone is combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB09285",
                        "description": "The risk or severity of hypertension can be increased when Morniflumate is combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB09295",
                        "description": "The risk or severity of hypertension can be increased when Talniflumate is combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB09307",
                        "description": "The risk or severity of hypertension can be increased when Oxaprotiline is combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB11455",
                        "description": "The risk or severity of hypertension can be increased when Robenacoxib is combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB11466",
                        "description": "The risk or severity of hypertension can be increased when Tepoxalin is combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB11481",
                        "description": "The risk or severity of hypertension can be increased when Atipamezole is combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB11518",
                        "description": "The risk or severity of hypertension can be increased when Flunixin is combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB12445",
                        "description": "The risk or severity of hypertension can be increased when Nitroaspirin is combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB12545",
                        "description": "The risk or severity of hypertension can be increased when Indobufen is combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB12551",
                        "description": "The risk or severity of hypertension can be increased when Idazoxan is combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB12610",
                        "description": "The risk or severity of hypertension can be increased when Ebselen is combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB12661",
                        "description": "The risk or severity of hypertension can be increased when Urapidil is combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB12930",
                        "description": "The risk or severity of hypertension can be increased when Opipramol is combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB13001",
                        "description": "The risk or severity of hypertension can be increased when Tinoridine is combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB13064",
                        "description": "The risk or severity of hypertension can be increased when Tramazoline is combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB13114",
                        "description": "The risk or severity of hypertension can be increased when Amitriptylinoxide is combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB13167",
                        "description": "The risk or severity of hypertension can be increased when Alclofenac is combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB13217",
                        "description": "The risk or severity of hypertension can be increased when Fentiazac is combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB13225",
                        "description": "The risk or severity of hypertension can be increased when Dibenzepin is combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB13232",
                        "description": "The risk or severity of hypertension can be increased when Suxibuzone is combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB13246",
                        "description": "The risk or severity of hypertension can be increased when Quinupramine is combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB13286",
                        "description": "The risk or severity of hypertension can be increased when Bumadizone is combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB13314",
                        "description": "The risk or severity of hypertension can be increased when Alminoprofen is combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB13323",
                        "description": "The risk or severity of hypertension can be increased when Trichloroethylene is combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB13341",
                        "description": "The risk or severity of hypertension can be increased when Fenozolone is combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB13371",
                        "description": "The risk or severity of hypertension can be increased when Dihydroergocristine is combined with Difenpiramide"
                    },
                    {
                        "drugbank-id": "DB13384",
                        "description": "The risk or severity of hypertension can be increased when Dihydroergocristine is combined with Melitracen"
                    },
                    {
                        "drugbank-id": "DB13407",
                        "description": "The risk or severity of hypertension can be increased when Dihydroergocristine is combined with Nifenazone"
                    },
                    {
                        "drugbank-id": "DB13411",
                        "description": "The risk or severity of hypertension can be increased when Dihydroergocristine is combined with Lofepramine"
                    },
                    {
                        "drugbank-id": "DB13432",
                        "description": "The risk or severity of hypertension can be increased when Dihydroergocristine is combined with Lonazolac"
                    },
                    {
                        "drugbank-id": "DB13453",
                        "description": "The risk or severity of hypertension can be increased when Dihydroergocristine is combined with Xenon"
                    },
                    {
                        "drugbank-id": "DB13481",
                        "description": "The risk or severity of hypertension can be increased when Dihydroergocristine is combined with Tenidap"
                    },
                    {
                        "drugbank-id": "DB13496",
                        "description": "The risk or severity of hypertension can be increased when Dihydroergocristine is combined with Iprindole"
                    },
                    {
                        "drugbank-id": "DB13510",
                        "description": "The risk or severity of hypertension can be increased when Dihydroergocristine is combined with Buflomedil"
                    },
                    {
                        "drugbank-id": "DB13520",
                        "description": "The risk or severity of hypertension can be increased when Dihydroergocristine is combined with Metergoline"
                    },
                    {
                        "drugbank-id": "DB13524",
                        "description": "The risk or severity of hypertension can be increased when Dihydroergocristine is combined with Propyphenazone"
                    },
                    {
                        "drugbank-id": "DB13527",
                        "description": "The risk or severity of hypertension can be increased when Dihydroergocristine is combined with Proglumetacin"
                    },
                    {
                        "drugbank-id": "DB13538",
                        "description": "The risk or severity of hypertension can be increased when Dihydroergocristine is combined with Guacetisal"
                    },
                    {
                        "drugbank-id": "DB13544",
                        "description": "The risk or severity of hypertension can be increased when Dihydroergocristine is combined with Ethenzamide"
                    },
                    {
                        "drugbank-id": "DB13598",
                        "description": "The risk or severity of hypertension can be increased when Dihydroergocristine is combined with Diethyl ether"
                    },
                    {
                        "drugbank-id": "DB13612",
                        "description": "The risk or severity of hypertension can be increased when Dihydroergocristine is combined with Carbaspirin calcium"
                    },
                    {
                        "drugbank-id": "DB13629",
                        "description": "The risk or severity of hypertension can be increased when Dihydroergocristine is combined with Mofebutazone"
                    },
                    {
                        "drugbank-id": "DB13649",
                        "description": "The risk or severity of hypertension can be increased when Dihydroergocristine is combined with Proquazone"
                    },
                    {
                        "drugbank-id": "DB13657",
                        "description": "The risk or severity of hypertension can be increased when Dihydroergocristine is combined with Benorilate"
                    },
                    {
                        "drugbank-id": "DB13722",
                        "description": "The risk or severity of hypertension can be increased when Dihydroergocristine is combined with Pirprofen"
                    },
                    {
                        "drugbank-id": "DB13782",
                        "description": "The risk or severity of hypertension can be increased when Dihydroergocristine is combined with Imipramine oxide"
                    },
                    {
                        "drugbank-id": "DB13783",
                        "description": "The risk or severity of hypertension can be increased when Dihydroergocristine is combined with Acemetacin"
                    },
                    {
                        "drugbank-id": "DB13852",
                        "description": "The risk or severity of hypertension can be increased when Dihydroergocristine is combined with Mefenorex"
                    },
                    {
                        "drugbank-id": "DB13860",
                        "description": "The risk or severity of hypertension can be increased when Dihydroergocristine is combined with Imidazole salicylate"
                    },
                    {
                        "drugbank-id": "DB13875",
                        "description": "The risk or severity of hypertension can be increased when Dihydroergocristine is combined with Harmaline"
                    },
                    {
                        "drugbank-id": "DB14059",
                        "description": "The risk or severity of hypertension can be increased when Dihydroergocristine is combined with SC 236"
                    },
                    {
                        "drugbank-id": "DB14060",
                        "description": "The risk or severity of hypertension can be increased when Dihydroergocristine is combined with NS 398"
                    },
                    {
                        "drugbank-id": "DB14231",
                        "description": "The risk or severity of hypertension can be increased when Dihydroergocristine is combined with Quinoline Yellow WS"
                    },
                    {
                        "drugbank-id": "DB00726",
                        "description": "The risk or severity of hypertension can be increased when Trimipramine is combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB01126",
                        "description": "The risk or severity of hypertension can be increased when Dutasteride is combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB00420",
                        "description": "The risk or severity of hypertension can be increased when Promazine is combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB00580",
                        "description": "The risk or severity of hypertension can be increased when Valdecoxib is combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB00656",
                        "description": "The risk or severity of hypertension can be increased when Trazodone is combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB00708",
                        "description": "The risk or severity of hypertension can be increased when Sufentanil is combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB00734",
                        "description": "The risk or severity of hypertension can be increased when Risperidone is combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB00814",
                        "description": "The risk or severity of hypertension can be increased when Meloxicam is combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB01028",
                        "description": "The risk or severity of hypertension can be increased when Methoxyflurane is combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB01037",
                        "description": "The risk or severity of hypertension can be increased when Selegiline is combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB01049",
                        "description": "The risk or severity of hypertension can be increased when Ergoloid mesylate is combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB01050",
                        "description": "The risk or severity of hypertension can be increased when Ibuprofen is combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB01159",
                        "description": "The risk or severity of hypertension can be increased when Halothane is combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB01216",
                        "description": "The risk or severity of hypertension can be increased when Finasteride is combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB01224",
                        "description": "The risk or severity of hypertension can be increased when Quetiapine is combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB01236",
                        "description": "The risk or severity of hypertension can be increased when Sevoflurane is combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB01267",
                        "description": "The risk or severity of hypertension can be increased when Paliperidone is combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB01392",
                        "description": "The risk or severity of hypertension can be increased when Yohimbine is combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB01424",
                        "description": "The risk or severity of hypertension can be increased when Aminophenazone is combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB01435",
                        "description": "The risk or severity of hypertension can be increased when Antipyrine is combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB01591",
                        "description": "The risk or severity of hypertension can be increased when Solifenacin is combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB04743",
                        "description": "The risk or severity of hypertension can be increased when Nimesulide is combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB04828",
                        "description": "The risk or severity of hypertension can be increased when Zomepirac is combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB04829",
                        "description": "The risk or severity of hypertension can be increased when Lysergic acid diethylamide is combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB04946",
                        "description": "The risk or severity of hypertension can be increased when Iloperidone is combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB06148",
                        "description": "The risk or severity of hypertension can be increased when Mianserin is combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB06216",
                        "description": "The risk or severity of hypertension can be increased when Asenapine is combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB06654",
                        "description": "The risk or severity of hypertension can be increased when Safinamide is combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB08439",
                        "description": "The risk or severity of hypertension can be increased when Parecoxib is combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB09216",
                        "description": "The risk or severity of hypertension can be increased when Tolfenamic acid is combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB09288",
                        "description": "The risk or severity of hypertension can be increased when Propacetamol is combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB12278",
                        "description": "The risk or severity of hypertension can be increased when Propiverine is combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB13399",
                        "description": "The risk or severity of hypertension can be increased when Dihydroergocristine is combined with Terguride"
                    },
                    {
                        "drugbank-id": "DB14185",
                        "description": "The risk or severity of hypertension can be increased when Dihydroergocristine is combined with Aripiprazole lauroxil"
                    },
                    {
                        "drugbank-id": "DB00321",
                        "description": "The risk or severity of hypertension can be increased when Amitriptyline is combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB00458",
                        "description": "The risk or severity of hypertension can be increased when Imipramine is combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB00490",
                        "description": "The risk or severity of hypertension can be increased when Buspirone is combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB01142",
                        "description": "The risk or severity of hypertension can be increased when Doxepin is combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB00802",
                        "description": "The risk or severity of hypertension can be increased when Alfentanil is combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB00813",
                        "description": "The risk or severity of hypertension can be increased when Fentanyl is combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB08815",
                        "description": "The risk or severity of hypertension can be increased when Lurasidone is combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB15685",
                        "description": "The risk or severity of hypertension can be increased when Dihydroergocristine is combined with Selpercatinib"
                    },
                    {
                        "drugbank-id": "DB09212",
                        "description": "The risk or severity of hypertension can be increased when Loxoprofen is combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB15965",
                        "description": "The risk or severity of hypertension can be increased when Dihydroergocristine is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB04871",
                        "description": "The risk or severity of adverse effects can be increased when Lorcaserin is combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB00727",
                        "description": "The bioavailability of Dihydroergocristine can be increased when combined with Nitroglycerin"
                    },
                    {
                        "drugbank-id": "DB08873",
                        "description": "The risk or severity of adverse effects can be increased when Boceprevir is combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB00834",
                        "description": "The serum concentration of Dihydroergocristine can be increased when it is combined with Mifepristone"
                    },
                    {
                        "drugbank-id": "DB01211",
                        "description": "The serum concentration of Dihydroergocristine can be increased when it is combined with Clarithromycin"
                    },
                    {
                        "drugbank-id": "DB01263",
                        "description": "The serum concentration of Dihydroergocristine can be increased when it is combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB09065",
                        "description": "The serum concentration of Dihydroergocristine can be increased when it is combined with Cobicistat"
                    },
                    {
                        "drugbank-id": "DB00211",
                        "description": "Dihydroergocristine may increase the hypertensive and vasoconstricting activities of Midodrine"
                    },
                    {
                        "drugbank-id": "DB00217",
                        "description": "Dihydroergocristine may increase the hypertensive and vasoconstricting activities of Bethanidine"
                    },
                    {
                        "drugbank-id": "DB00221",
                        "description": "Dihydroergocristine may increase the hypertensive and vasoconstricting activities of Isoetharine"
                    },
                    {
                        "drugbank-id": "DB00292",
                        "description": "Dihydroergocristine may increase the hypertensive and vasoconstricting activities of Etomidate"
                    },
                    {
                        "drugbank-id": "DB00368",
                        "description": "Dihydroergocristine may increase the hypertensive and vasoconstricting activities of Norepinephrine"
                    },
                    {
                        "drugbank-id": "DB00388",
                        "description": "Dihydroergocristine may increase the hypertensive and vasoconstricting activities of Phenylephrine"
                    },
                    {
                        "drugbank-id": "DB00397",
                        "description": "Dihydroergocristine may increase the hypertensive and vasoconstricting activities of Phenylpropanolamine"
                    },
                    {
                        "drugbank-id": "DB00610",
                        "description": "Dihydroergocristine may increase the hypertensive and vasoconstricting activities of Metaraminol"
                    },
                    {
                        "drugbank-id": "DB00629",
                        "description": "Dihydroergocristine may increase the hypertensive and vasoconstricting activities of Guanabenz"
                    },
                    {
                        "drugbank-id": "DB00633",
                        "description": "Dihydroergocristine may increase the hypertensive and vasoconstricting activities of Dexmedetomidine"
                    },
                    {
                        "drugbank-id": "DB00668",
                        "description": "Dihydroergocristine may increase the hypertensive and vasoconstricting activities of Epinephrine"
                    },
                    {
                        "drugbank-id": "DB00697",
                        "description": "Dihydroergocristine may increase the hypertensive and vasoconstricting activities of Tizanidine"
                    },
                    {
                        "drugbank-id": "DB00723",
                        "description": "Dihydroergocristine may increase the hypertensive and vasoconstricting activities of Methoxamine"
                    },
                    {
                        "drugbank-id": "DB00816",
                        "description": "Dihydroergocristine may increase the hypertensive and vasoconstricting activities of Orciprenaline"
                    },
                    {
                        "drugbank-id": "DB00841",
                        "description": "Dihydroergocristine may increase the hypertensive and vasoconstricting activities of Dobutamine"
                    },
                    {
                        "drugbank-id": "DB00867",
                        "description": "Dihydroergocristine may increase the hypertensive and vasoconstricting activities of Ritodrine"
                    },
                    {
                        "drugbank-id": "DB00871",
                        "description": "Dihydroergocristine may increase the hypertensive and vasoconstricting activities of Terbutaline"
                    },
                    {
                        "drugbank-id": "DB00901",
                        "description": "Dihydroergocristine may increase the hypertensive and vasoconstricting activities of Bitolterol"
                    },
                    {
                        "drugbank-id": "DB00935",
                        "description": "Dihydroergocristine may increase the hypertensive and vasoconstricting activities of Oxymetazoline"
                    },
                    {
                        "drugbank-id": "DB00938",
                        "description": "Dihydroergocristine may increase the hypertensive and vasoconstricting activities of Salmeterol"
                    },
                    {
                        "drugbank-id": "DB00968",
                        "description": "Dihydroergocristine may increase the hypertensive and vasoconstricting activities of Methyldopa"
                    },
                    {
                        "drugbank-id": "DB00983",
                        "description": "Dihydroergocristine may increase the hypertensive and vasoconstricting activities of Formoterol"
                    },
                    {
                        "drugbank-id": "DB01001",
                        "description": "Dihydroergocristine may increase the hypertensive and vasoconstricting activities of Salbutamol"
                    },
                    {
                        "drugbank-id": "DB01018",
                        "description": "Dihydroergocristine may increase the hypertensive and vasoconstricting activities of Guanfacine"
                    },
                    {
                        "drugbank-id": "DB01064",
                        "description": "Dihydroergocristine may increase the hypertensive and vasoconstricting activities of Isoprenaline"
                    },
                    {
                        "drugbank-id": "DB01102",
                        "description": "Dihydroergocristine may increase the hypertensive and vasoconstricting activities of Arbutamine"
                    },
                    {
                        "drugbank-id": "DB01186",
                        "description": "Dihydroergocristine may increase the hypertensive and vasoconstricting activities of Pergolide"
                    },
                    {
                        "drugbank-id": "DB01253",
                        "description": "Dihydroergocristine may increase the hypertensive and vasoconstricting activities of Ergometrine"
                    },
                    {
                        "drugbank-id": "DB01274",
                        "description": "Dihydroergocristine may increase the hypertensive and vasoconstricting activities of Arformoterol"
                    },
                    {
                        "drugbank-id": "DB01288",
                        "description": "Dihydroergocristine may increase the hypertensive and vasoconstricting activities of Fenoterol"
                    },
                    {
                        "drugbank-id": "DB01291",
                        "description": "Dihydroergocristine may increase the hypertensive and vasoconstricting activities of Pirbuterol"
                    },
                    {
                        "drugbank-id": "DB01363",
                        "description": "Dihydroergocristine may increase the hypertensive and vasoconstricting activities of Ephedra sinica root"
                    },
                    {
                        "drugbank-id": "DB01364",
                        "description": "Dihydroergocristine may increase the hypertensive and vasoconstricting activities of Ephedrine"
                    },
                    {
                        "drugbank-id": "DB01366",
                        "description": "Dihydroergocristine may increase the hypertensive and vasoconstricting activities of Procaterol"
                    },
                    {
                        "drugbank-id": "DB01407",
                        "description": "Dihydroergocristine may increase the hypertensive and vasoconstricting activities of Clenbuterol"
                    },
                    {
                        "drugbank-id": "DB01408",
                        "description": "Dihydroergocristine may increase the hypertensive and vasoconstricting activities of Bambuterol"
                    },
                    {
                        "drugbank-id": "DB01472",
                        "description": "Dihydroergocristine may increase the hypertensive and vasoconstricting activities of 4 Methoxyamphetamine"
                    },
                    {
                        "drugbank-id": "DB01537",
                        "description": "Dihydroergocristine may increase the hypertensive and vasoconstricting activities of 4 Bromo 2 5 dimethoxyphenethylamine"
                    },
                    {
                        "drugbank-id": "DB01579",
                        "description": "Dihydroergocristine may increase the hypertensive and vasoconstricting activities of Phendimetrazine"
                    },
                    {
                        "drugbank-id": "DB04846",
                        "description": "Dihydroergocristine may increase the hypertensive and vasoconstricting activities of Celiprolol"
                    },
                    {
                        "drugbank-id": "DB04861",
                        "description": "Dihydroergocristine may increase the hypertensive and vasoconstricting activities of Nebivolol"
                    },
                    {
                        "drugbank-id": "DB04948",
                        "description": "Dihydroergocristine may increase the hypertensive and vasoconstricting activities of Lofexidine"
                    },
                    {
                        "drugbank-id": "DB05039",
                        "description": "Dihydroergocristine may increase the hypertensive and vasoconstricting activities of Indacaterol"
                    },
                    {
                        "drugbank-id": "DB05395",
                        "description": "Dihydroergocristine may increase the hypertensive and vasoconstricting activities of Amibegron"
                    },
                    {
                        "drugbank-id": "DB06152",
                        "description": "Dihydroergocristine may increase the hypertensive and vasoconstricting activities of Nylidrin"
                    },
                    {
                        "drugbank-id": "DB06190",
                        "description": "Dihydroergocristine may increase the hypertensive and vasoconstricting activities of Solabegron"
                    },
                    {
                        "drugbank-id": "DB06262",
                        "description": "Dihydroergocristine may increase the hypertensive and vasoconstricting activities of Droxidopa"
                    },
                    {
                        "drugbank-id": "DB06694",
                        "description": "Dihydroergocristine may increase the hypertensive and vasoconstricting activities of Xylometazoline"
                    },
                    {
                        "drugbank-id": "DB06706",
                        "description": "Dihydroergocristine may increase the hypertensive and vasoconstricting activities of Isometheptene"
                    },
                    {
                        "drugbank-id": "DB06707",
                        "description": "Dihydroergocristine may increase the hypertensive and vasoconstricting activities of Levonordefrin"
                    },
                    {
                        "drugbank-id": "DB06711",
                        "description": "Dihydroergocristine may increase the hypertensive and vasoconstricting activities of Naphazoline"
                    },
                    {
                        "drugbank-id": "DB06764",
                        "description": "Dihydroergocristine may increase the hypertensive and vasoconstricting activities of Tetryzoline"
                    },
                    {
                        "drugbank-id": "DB06814",
                        "description": "Dihydroergocristine may increase the hypertensive and vasoconstricting activities of Protokylol"
                    },
                    {
                        "drugbank-id": "DB08893",
                        "description": "Dihydroergocristine may increase the hypertensive and vasoconstricting activities of Mirabegron"
                    },
                    {
                        "drugbank-id": "DB08925",
                        "description": "Dihydroergocristine may increase the hypertensive and vasoconstricting activities of Adrafinil"
                    },
                    {
                        "drugbank-id": "DB08941",
                        "description": "Dihydroergocristine may increase the hypertensive and vasoconstricting activities of Isoxsuprine"
                    },
                    {
                        "drugbank-id": "DB08957",
                        "description": "Dihydroergocristine may increase the hypertensive and vasoconstricting activities of Hexoprenaline"
                    },
                    {
                        "drugbank-id": "DB08985",
                        "description": "Dihydroergocristine may increase the hypertensive and vasoconstricting activities of Etilefrine"
                    },
                    {
                        "drugbank-id": "DB09080",
                        "description": "Dihydroergocristine may increase the hypertensive and vasoconstricting activities of Olodaterol"
                    },
                    {
                        "drugbank-id": "DB09082",
                        "description": "Dihydroergocristine may increase the hypertensive and vasoconstricting activities of Vilanterol"
                    },
                    {
                        "drugbank-id": "DB09202",
                        "description": "Dihydroergocristine may increase the hypertensive and vasoconstricting activities of Cirazoline"
                    },
                    {
                        "drugbank-id": "DB09203",
                        "description": "Dihydroergocristine may increase the hypertensive and vasoconstricting activities of Synephrine"
                    },
                    {
                        "drugbank-id": "DB09242",
                        "description": "Dihydroergocristine may increase the hypertensive and vasoconstricting activities of Moxonidine"
                    },
                    {
                        "drugbank-id": "DB09273",
                        "description": "Dihydroergocristine may increase the hypertensive and vasoconstricting activities of Doxofylline"
                    },
                    {
                        "drugbank-id": "DB11124",
                        "description": "Dihydroergocristine may increase the hypertensive and vasoconstricting activities of Racepinephrine"
                    },
                    {
                        "drugbank-id": "DB11278",
                        "description": "Dihydroergocristine may increase the hypertensive and vasoconstricting activities of DL Methylephedrine"
                    },
                    {
                        "drugbank-id": "DB11373",
                        "description": "Dihydroergocristine may increase the hypertensive and vasoconstricting activities of Amitraz"
                    },
                    {
                        "drugbank-id": "DB11428",
                        "description": "Dihydroergocristine may increase the hypertensive and vasoconstricting activities of Medetomidine"
                    },
                    {
                        "drugbank-id": "DB11477",
                        "description": "Dihydroergocristine may increase the hypertensive and vasoconstricting activities of Xylazine"
                    },
                    {
                        "drugbank-id": "DB11541",
                        "description": "Dihydroergocristine may increase the hypertensive and vasoconstricting activities of Ractopamine"
                    },
                    {
                        "drugbank-id": "DB11543",
                        "description": "Dihydroergocristine may increase the hypertensive and vasoconstricting activities of Romifidine"
                    },
                    {
                        "drugbank-id": "DB11556",
                        "description": "Dihydroergocristine may increase the hypertensive and vasoconstricting activities of Detomidine"
                    },
                    {
                        "drugbank-id": "DB11587",
                        "description": "Dihydroergocristine may increase the hypertensive and vasoconstricting activities of Etafedrine"
                    },
                    {
                        "drugbank-id": "DB11738",
                        "description": "Dihydroergocristine may increase the hypertensive and vasoconstricting activities of Rilmenidine"
                    },
                    {
                        "drugbank-id": "DB11785",
                        "description": "Dihydroergocristine may increase the hypertensive and vasoconstricting activities of Anisodamine"
                    },
                    {
                        "drugbank-id": "DB11871",
                        "description": "Dihydroergocristine may increase the hypertensive and vasoconstricting activities of PF 00610355"
                    },
                    {
                        "drugbank-id": "DB12100",
                        "description": "Dihydroergocristine may increase the hypertensive and vasoconstricting activities of Abediterol"
                    },
                    {
                        "drugbank-id": "DB12248",
                        "description": "Dihydroergocristine may increase the hypertensive and vasoconstricting activities of Tulobuterol"
                    },
                    {
                        "drugbank-id": "DB12313",
                        "description": "Dihydroergocristine may increase the hypertensive and vasoconstricting activities of Dopexamine"
                    },
                    {
                        "drugbank-id": "DB12526",
                        "description": "Dihydroergocristine may increase the hypertensive and vasoconstricting activities of Batefenterol"
                    },
                    {
                        "drugbank-id": "DB12779",
                        "description": "Dihydroergocristine may increase the hypertensive and vasoconstricting activities of Higenamine"
                    },
                    {
                        "drugbank-id": "DB12846",
                        "description": "Dihydroergocristine may increase the hypertensive and vasoconstricting activities of Reproterol"
                    },
                    {
                        "drugbank-id": "DB13139",
                        "description": "Dihydroergocristine may increase the hypertensive and vasoconstricting activities of Levosalbutamol"
                    },
                    {
                        "drugbank-id": "DB13251",
                        "description": "Dihydroergocristine may increase the hypertensive and vasoconstricting activities of Octopamine"
                    },
                    {
                        "drugbank-id": "DB13378",
                        "description": "Dihydroergocristine may increase the hypertensive and vasoconstricting activities of Norfenefrine"
                    },
                    {
                        "drugbank-id": "DB13398",
                        "description": "Dihydroergocristine may increase the hypertensive and vasoconstricting activities of Oxyfedrine"
                    },
                    {
                        "drugbank-id": "DB13559",
                        "description": "Dihydroergocristine may increase the hypertensive and vasoconstricting activities of Rimiterol"
                    },
                    {
                        "drugbank-id": "DB13692",
                        "description": "Dihydroergocristine may increase the hypertensive and vasoconstricting activities of Tretoquinol"
                    },
                    {
                        "drugbank-id": "DB13777",
                        "description": "Dihydroergocristine may increase the hypertensive and vasoconstricting activities of Prenalterol"
                    },
                    {
                        "drugbank-id": "DB13781",
                        "description": "Dihydroergocristine may increase the hypertensive and vasoconstricting activities of Xamoterol"
                    },
                    {
                        "drugbank-id": "DB14752",
                        "description": "Dihydroergocristine may increase the hypertensive and vasoconstricting activities of Racephedrine"
                    },
                    {
                        "drugbank-id": "DB00575",
                        "description": "Dihydroergocristine may increase the hypertensive and vasoconstricting activities of Clonidine"
                    },
                    {
                        "drugbank-id": "DB01200",
                        "description": "Dihydroergocristine may increase the hypertensive and vasoconstricting activities of Bromocriptine"
                    },
                    {
                        "drugbank-id": "DB14547",
                        "description": "Dihydroergocristine may increase the hypertensive and vasoconstricting activities of Chloride ion"
                    },
                    {
                        "drugbank-id": "DB00187",
                        "description": "Esmolol may increase the vasoconstricting activities of Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB00195",
                        "description": "Betaxolol may increase the vasoconstricting activities of Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB00264",
                        "description": "Metoprolol may increase the vasoconstricting activities of Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB00335",
                        "description": "Atenolol may increase the vasoconstricting activities of Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB00373",
                        "description": "Timolol may increase the vasoconstricting activities of Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB00489",
                        "description": "Sotalol may increase the vasoconstricting activities of Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB00571",
                        "description": "Propranolol may increase the vasoconstricting activities of Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB00598",
                        "description": "Labetalol may increase the vasoconstricting activities of Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB00612",
                        "description": "Bisoprolol may increase the vasoconstricting activities of Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB00866",
                        "description": "Alprenolol may increase the vasoconstricting activities of Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB00960",
                        "description": "Pindolol may increase the vasoconstricting activities of Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB01136",
                        "description": "Carvedilol may increase the vasoconstricting activities of Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB01182",
                        "description": "Propafenone may increase the vasoconstricting activities of Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB01193",
                        "description": "Acebutolol may increase the vasoconstricting activities of Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB01203",
                        "description": "Nadolol may increase the vasoconstricting activities of Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB01295",
                        "description": "Bevantolol may increase the vasoconstricting activities of Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB01297",
                        "description": "Practolol may increase the vasoconstricting activities of Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB01359",
                        "description": "Penbutolol may increase the vasoconstricting activities of Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB01580",
                        "description": "Oxprenolol may increase the vasoconstricting activities of Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB03322",
                        "description": "Dexpropranolol may increase the vasoconstricting activities of Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB06726",
                        "description": "Bufuralol may increase the vasoconstricting activities of Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB08807",
                        "description": "Bopindolol may increase the vasoconstricting activities of Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB08808",
                        "description": "Bupranolol may increase the vasoconstricting activities of Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB08952",
                        "description": "Indenolol may increase the vasoconstricting activities of Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB09204",
                        "description": "Arotinolol may increase the vasoconstricting activities of Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB09351",
                        "description": "Levobetaxolol may increase the vasoconstricting activities of Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB11770",
                        "description": "Talinolol may increase the vasoconstricting activities of Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB12752",
                        "description": "Bucindolol may increase the vasoconstricting activities of Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB13443",
                        "description": "Esatenolol may increase the vasoconstricting activities of Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB13508",
                        "description": "Cloranolol may increase the vasoconstricting activities of Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB13530",
                        "description": "Mepindolol may increase the vasoconstricting activities of Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB13757",
                        "description": "Epanolol may increase the vasoconstricting activities of Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB13775",
                        "description": "Tertatolol may increase the vasoconstricting activities of Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB12212",
                        "description": "Dihydroergocristine may increase the vasoconstricting activities of Landiolol"
                    },
                    {
                        "drugbank-id": "DB00307",
                        "description": "The metabolism of Dihydroergocristine can be increased when combined with Bexarotene"
                    },
                    {
                        "drugbank-id": "DB00607",
                        "description": "The metabolism of Dihydroergocristine can be increased when combined with Nafcillin"
                    },
                    {
                        "drugbank-id": "DB00745",
                        "description": "The metabolism of Dihydroergocristine can be increased when combined with Modafinil"
                    },
                    {
                        "drugbank-id": "DB06414",
                        "description": "The metabolism of Dihydroergocristine can be increased when combined with Etravirine"
                    },
                    {
                        "drugbank-id": "DB06442",
                        "description": "The metabolism of Dihydroergocristine can be increased when combined with Avasimibe"
                    },
                    {
                        "drugbank-id": "DB14240",
                        "description": "The metabolism of Dihydroergocristine can be increased when combined with Echinacea"
                    },
                    {
                        "drugbank-id": "DB00312",
                        "description": "The metabolism of Dihydroergocristine can be increased when combined with Pentobarbital"
                    },
                    {
                        "drugbank-id": "DB00648",
                        "description": "The metabolism of Dihydroergocristine can be increased when combined with Mitotane"
                    },
                    {
                        "drugbank-id": "DB00794",
                        "description": "The metabolism of Dihydroergocristine can be increased when combined with Primidone"
                    },
                    {
                        "drugbank-id": "DB01174",
                        "description": "The metabolism of Dihydroergocristine can be increased when combined with Phenobarbital"
                    },
                    {
                        "drugbank-id": "DB01220",
                        "description": "The metabolism of Dihydroergocristine can be increased when combined with Rifaximin"
                    },
                    {
                        "drugbank-id": "DB01234",
                        "description": "The metabolism of Dihydroergocristine can be increased when combined with Dexamethasone"
                    },
                    {
                        "drugbank-id": "DB01323",
                        "description": "The metabolism of Dihydroergocristine can be increased when combined with St John s Wort"
                    },
                    {
                        "drugbank-id": "DB06595",
                        "description": "The metabolism of Dihydroergocristine can be increased when combined with Midostaurin"
                    },
                    {
                        "drugbank-id": "DB08899",
                        "description": "The metabolism of Dihydroergocristine can be increased when combined with Enzalutamide"
                    },
                    {
                        "drugbank-id": "DB09280",
                        "description": "The metabolism of Dihydroergocristine can be increased when combined with Lumacaftor"
                    },
                    {
                        "drugbank-id": "DB11753",
                        "description": "The metabolism of Dihydroergocristine can be increased when combined with Rifamycin"
                    },
                    {
                        "drugbank-id": "DB11901",
                        "description": "The metabolism of Dihydroergocristine can be increased when combined with Apalutamide"
                    },
                    {
                        "drugbank-id": "DB00564",
                        "description": "The metabolism of Carbamazepine can be increased when combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB01045",
                        "description": "The metabolism of Rifampicin can be increased when combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB00176",
                        "description": "The metabolism of Dihydroergocristine can be decreased when combined with Fluvoxamine"
                    },
                    {
                        "drugbank-id": "DB00196",
                        "description": "The metabolism of Dihydroergocristine can be decreased when combined with Fluconazole"
                    },
                    {
                        "drugbank-id": "DB00270",
                        "description": "The metabolism of Dihydroergocristine can be decreased when combined with Isradipine"
                    },
                    {
                        "drugbank-id": "DB00343",
                        "description": "The metabolism of Dihydroergocristine can be decreased when combined with Diltiazem"
                    },
                    {
                        "drugbank-id": "DB00622",
                        "description": "The metabolism of Dihydroergocristine can be decreased when combined with Nicardipine"
                    },
                    {
                        "drugbank-id": "DB00951",
                        "description": "The metabolism of Dihydroergocristine can be decreased when combined with Isoniazid"
                    },
                    {
                        "drugbank-id": "DB01087",
                        "description": "The metabolism of Dihydroergocristine can be decreased when combined with Primaquine"
                    },
                    {
                        "drugbank-id": "DB01110",
                        "description": "The metabolism of Dihydroergocristine can be decreased when combined with Miconazole"
                    },
                    {
                        "drugbank-id": "DB01406",
                        "description": "The metabolism of Dihydroergocristine can be decreased when combined with Danazol"
                    },
                    {
                        "drugbank-id": "DB04832",
                        "description": "The metabolism of Dihydroergocristine can be decreased when combined with Zimelidine"
                    },
                    {
                        "drugbank-id": "DB04896",
                        "description": "The metabolism of Dihydroergocristine can be decreased when combined with Milnacipran"
                    },
                    {
                        "drugbank-id": "DB06700",
                        "description": "The metabolism of Dihydroergocristine can be decreased when combined with Desvenlafaxine"
                    },
                    {
                        "drugbank-id": "DB06712",
                        "description": "The metabolism of Dihydroergocristine can be decreased when combined with Nilvadipine"
                    },
                    {
                        "drugbank-id": "DB06731",
                        "description": "The metabolism of Dihydroergocristine can be decreased when combined with Seproxetine"
                    },
                    {
                        "drugbank-id": "DB08882",
                        "description": "The metabolism of Dihydroergocristine can be decreased when combined with Linagliptin"
                    },
                    {
                        "drugbank-id": "DB08953",
                        "description": "The metabolism of Dihydroergocristine can be decreased when combined with Indalpine"
                    },
                    {
                        "drugbank-id": "DB09048",
                        "description": "The metabolism of Dihydroergocristine can be decreased when combined with Netupitant"
                    },
                    {
                        "drugbank-id": "DB09227",
                        "description": "The metabolism of Dihydroergocristine can be decreased when combined with Barnidipine"
                    },
                    {
                        "drugbank-id": "DB09231",
                        "description": "The metabolism of Dihydroergocristine can be decreased when combined with Benidipine"
                    },
                    {
                        "drugbank-id": "DB14019",
                        "description": "The metabolism of Dihydroergocristine can be decreased when combined with Fosnetupitant"
                    },
                    {
                        "drugbank-id": "DB00537",
                        "description": "The metabolism of Dihydroergocristine can be decreased when combined with Ciprofloxacin"
                    },
                    {
                        "drugbank-id": "DB00661",
                        "description": "The metabolism of Dihydroergocristine can be decreased when combined with Verapamil"
                    },
                    {
                        "drugbank-id": "DB00227",
                        "description": "The metabolism of Dihydroergocristine can be decreased when combined with Lovastatin"
                    },
                    {
                        "drugbank-id": "DB00673",
                        "description": "The metabolism of Dihydroergocristine can be decreased when combined with Aprepitant"
                    },
                    {
                        "drugbank-id": "DB00363",
                        "description": "The metabolism of Dihydroergocristine can be decreased when combined with Clozapine"
                    },
                    {
                        "drugbank-id": "DB11633",
                        "description": "The metabolism of Dihydroergocristine can be decreased when combined with Isavuconazole"
                    },
                    {
                        "drugbank-id": "DB15982",
                        "description": "The metabolism of Dihydroergocristine can be decreased when combined with Berotralstat"
                    },
                    {
                        "drugbank-id": "DB00582",
                        "description": "The metabolism of Dihydroergocristine can be decreased when combined with Voriconazole"
                    },
                    {
                        "drugbank-id": "DB00625",
                        "description": "The metabolism of Dihydroergocristine can be decreased when combined with Efavirenz"
                    },
                    {
                        "drugbank-id": "DB00705",
                        "description": "The metabolism of Dihydroergocristine can be decreased when combined with Delavirdine"
                    },
                    {
                        "drugbank-id": "DB00836",
                        "description": "The metabolism of Dihydroergocristine can be decreased when combined with Loperamide"
                    },
                    {
                        "drugbank-id": "DB01026",
                        "description": "The metabolism of Dihydroergocristine can be decreased when combined with Ketoconazole"
                    },
                    {
                        "drugbank-id": "DB01072",
                        "description": "The metabolism of Dihydroergocristine can be decreased when combined with Atazanavir"
                    },
                    {
                        "drugbank-id": "DB01149",
                        "description": "The metabolism of Dihydroergocristine can be decreased when combined with Nefazodone"
                    },
                    {
                        "drugbank-id": "DB01167",
                        "description": "The metabolism of Dihydroergocristine can be decreased when combined with Itraconazole"
                    },
                    {
                        "drugbank-id": "DB01183",
                        "description": "The metabolism of Dihydroergocristine can be decreased when combined with Naloxone"
                    },
                    {
                        "drugbank-id": "DB02520",
                        "description": "The metabolism of Dihydroergocristine can be decreased when combined with Ditiocarb"
                    },
                    {
                        "drugbank-id": "DB04868",
                        "description": "The metabolism of Dihydroergocristine can be decreased when combined with Nilotinib"
                    },
                    {
                        "drugbank-id": "DB05521",
                        "description": "The metabolism of Dihydroergocristine can be decreased when combined with Telaprevir"
                    },
                    {
                        "drugbank-id": "DB09101",
                        "description": "The metabolism of Dihydroergocristine can be decreased when combined with Elvitegravir"
                    },
                    {
                        "drugbank-id": "DB09118",
                        "description": "The metabolism of Dihydroergocristine can be decreased when combined with Stiripentol"
                    },
                    {
                        "drugbank-id": "DB11730",
                        "description": "The metabolism of Dihydroergocristine can be decreased when combined with Ribociclib"
                    },
                    {
                        "drugbank-id": "DB11779",
                        "description": "The metabolism of Dihydroergocristine can be decreased when combined with Danoprevir"
                    },
                    {
                        "drugbank-id": "DB00763",
                        "description": "The metabolism of Dihydroergocristine can be decreased when combined with Methimazole"
                    },
                    {
                        "drugbank-id": "DB00342",
                        "description": "The metabolism of Terfenadine can be decreased when combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB00696",
                        "description": "The metabolism of Ergotamine can be decreased when combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB00872",
                        "description": "The metabolism of Conivaptan can be decreased when combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB00932",
                        "description": "The metabolism of Tipranavir can be decreased when combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB01232",
                        "description": "The metabolism of Saquinavir can be decreased when combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB01264",
                        "description": "The metabolism of Darunavir can be decreased when combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB06448",
                        "description": "The metabolism of Dihydroergocristine can be decreased when combined with Lonafarnib"
                    },
                    {
                        "drugbank-id": "DB00246",
                        "description": "Dihydroergocristine may increase the vasoconstricting activities of Ziprasidone"
                    },
                    {
                        "drugbank-id": "DB00248",
                        "description": "Dihydroergocristine may increase the vasoconstricting activities of Cabergoline"
                    },
                    {
                        "drugbank-id": "DB00315",
                        "description": "Dihydroergocristine may increase the vasoconstricting activities of Zolmitriptan"
                    },
                    {
                        "drugbank-id": "DB00589",
                        "description": "Dihydroergocristine may increase the vasoconstricting activities of Lisuride"
                    },
                    {
                        "drugbank-id": "DB00669",
                        "description": "Dihydroergocristine may increase the vasoconstricting activities of Sumatriptan"
                    },
                    {
                        "drugbank-id": "DB00918",
                        "description": "Dihydroergocristine may increase the vasoconstricting activities of Almotriptan"
                    },
                    {
                        "drugbank-id": "DB00952",
                        "description": "Dihydroergocristine may increase the vasoconstricting activities of Naratriptan"
                    },
                    {
                        "drugbank-id": "DB00953",
                        "description": "Dihydroergocristine may increase the vasoconstricting activities of Rizatriptan"
                    },
                    {
                        "drugbank-id": "DB00998",
                        "description": "Dihydroergocristine may increase the vasoconstricting activities of Frovatriptan"
                    },
                    {
                        "drugbank-id": "DB01238",
                        "description": "Dihydroergocristine may increase the vasoconstricting activities of Aripiprazole"
                    },
                    {
                        "drugbank-id": "DB04908",
                        "description": "Dihydroergocristine may increase the vasoconstricting activities of Flibanserin"
                    },
                    {
                        "drugbank-id": "DB05271",
                        "description": "Dihydroergocristine may increase the vasoconstricting activities of Rotigotine"
                    },
                    {
                        "drugbank-id": "DB05562",
                        "description": "Dihydroergocristine may increase the vasoconstricting activities of Naluzotan"
                    },
                    {
                        "drugbank-id": "DB06016",
                        "description": "Dihydroergocristine may increase the vasoconstricting activities of Cariprazine"
                    },
                    {
                        "drugbank-id": "DB06684",
                        "description": "Dihydroergocristine may increase the vasoconstricting activities of Vilazodone"
                    },
                    {
                        "drugbank-id": "DB08810",
                        "description": "Dihydroergocristine may increase the vasoconstricting activities of Cinitapride"
                    },
                    {
                        "drugbank-id": "DB09061",
                        "description": "Dihydroergocristine may increase the vasoconstricting activities of Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB09068",
                        "description": "Dihydroergocristine may increase the vasoconstricting activities of Vortioxetine"
                    },
                    {
                        "drugbank-id": "DB09128",
                        "description": "Dihydroergocristine may increase the vasoconstricting activities of Brexpiprazole"
                    },
                    {
                        "drugbank-id": "DB11755",
                        "description": "Dihydroergocristine may increase the vasoconstricting activities of Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB12361",
                        "description": "Dihydroergocristine may increase the vasoconstricting activities of Piclozotan"
                    },
                    {
                        "drugbank-id": "DB14010",
                        "description": "Dihydroergocristine may increase the vasoconstricting activities of 5 methoxy N N dimethyltryptamine"
                    },
                    {
                        "drugbank-id": "DB00216",
                        "description": "Dihydroergocristine may increase the vasoconstricting activities of Eletriptan"
                    },
                    {
                        "drugbank-id": "DB00320",
                        "description": "Dihydroergocristine may increase the vasoconstricting activities of Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB00207",
                        "description": "The serum concentration of Dihydroergocristine can be increased when it is combined with Azithromycin"
                    },
                    {
                        "drugbank-id": "DB00954",
                        "description": "The serum concentration of Dihydroergocristine can be increased when it is combined with Dirithromycin"
                    },
                    {
                        "drugbank-id": "DB01152",
                        "description": "The serum concentration of Dihydroergocristine can be increased when it is combined with Candicidin"
                    },
                    {
                        "drugbank-id": "DB01321",
                        "description": "The serum concentration of Dihydroergocristine can be increased when it is combined with Josamycin"
                    },
                    {
                        "drugbank-id": "DB01873",
                        "description": "The serum concentration of Dihydroergocristine can be increased when it is combined with Epothilone D"
                    },
                    {
                        "drugbank-id": "DB03010",
                        "description": "The serum concentration of Dihydroergocristine can be increased when it is combined with Patupilone"
                    },
                    {
                        "drugbank-id": "DB04070",
                        "description": "The serum concentration of Dihydroergocristine can be increased when it is combined with 6 Deoxyerythronolide B"
                    },
                    {
                        "drugbank-id": "DB04845",
                        "description": "The serum concentration of Dihydroergocristine can be increased when it is combined with Ixabepilone"
                    },
                    {
                        "drugbank-id": "DB05903",
                        "description": "The serum concentration of Dihydroergocristine can be increased when it is combined with KOS 1584"
                    },
                    {
                        "drugbank-id": "DB06233",
                        "description": "The serum concentration of Dihydroergocristine can be increased when it is combined with Ridaforolimus"
                    },
                    {
                        "drugbank-id": "DB06318",
                        "description": "The serum concentration of Dihydroergocristine can be increased when it is combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB06342",
                        "description": "The serum concentration of Dihydroergocristine can be increased when it is combined with Coltuximab ravtansine"
                    },
                    {
                        "drugbank-id": "DB06587",
                        "description": "The serum concentration of Dihydroergocristine can be increased when it is combined with Mitemcinal"
                    },
                    {
                        "drugbank-id": "DB07348",
                        "description": "The serum concentration of Dihydroergocristine can be increased when it is combined with Brefeldin A"
                    },
                    {
                        "drugbank-id": "DB09308",
                        "description": "The serum concentration of Dihydroergocristine can be increased when it is combined with Solithromycin"
                    },
                    {
                        "drugbank-id": "DB09309",
                        "description": "The serum concentration of Dihydroergocristine can be increased when it is combined with Kitasamycin"
                    },
                    {
                        "drugbank-id": "DB11383",
                        "description": "The serum concentration of Dihydroergocristine can be increased when it is combined with Carbomycin"
                    },
                    {
                        "drugbank-id": "DB11400",
                        "description": "The serum concentration of Dihydroergocristine can be increased when it is combined with Doramectin"
                    },
                    {
                        "drugbank-id": "DB11405",
                        "description": "The serum concentration of Dihydroergocristine can be increased when it is combined with Eprinomectin"
                    },
                    {
                        "drugbank-id": "DB11442",
                        "description": "The serum concentration of Dihydroergocristine can be increased when it is combined with Oleandomycin"
                    },
                    {
                        "drugbank-id": "DB11459",
                        "description": "The serum concentration of Dihydroergocristine can be increased when it is combined with Selamectin"
                    },
                    {
                        "drugbank-id": "DB11470",
                        "description": "The serum concentration of Dihydroergocristine can be increased when it is combined with Tildipirosin"
                    },
                    {
                        "drugbank-id": "DB11471",
                        "description": "The serum concentration of Dihydroergocristine can be increased when it is combined with Tilmicosin"
                    },
                    {
                        "drugbank-id": "DB11475",
                        "description": "The serum concentration of Dihydroergocristine can be increased when it is combined with Tylosin"
                    },
                    {
                        "drugbank-id": "DB11554",
                        "description": "The serum concentration of Dihydroergocristine can be increased when it is combined with Tylvalosin"
                    },
                    {
                        "drugbank-id": "DB11752",
                        "description": "The serum concentration of Dihydroergocristine can be increased when it is combined with Bryostatin 1"
                    },
                    {
                        "drugbank-id": "DB12089",
                        "description": "The serum concentration of Dihydroergocristine can be increased when it is combined with Lorvotuzumab mertansine"
                    },
                    {
                        "drugbank-id": "DB12266",
                        "description": "The serum concentration of Dihydroergocristine can be increased when it is combined with Epofolate"
                    },
                    {
                        "drugbank-id": "DB12391",
                        "description": "The serum concentration of Dihydroergocristine can be increased when it is combined with Sagopilone"
                    },
                    {
                        "drugbank-id": "DB12489",
                        "description": "The serum concentration of Dihydroergocristine can be increased when it is combined with Mirvetuximab Soravtansine"
                    },
                    {
                        "drugbank-id": "DB13179",
                        "description": "The serum concentration of Dihydroergocristine can be increased when it is combined with Troleandomycin"
                    },
                    {
                        "drugbank-id": "DB13287",
                        "description": "The serum concentration of Dihydroergocristine can be increased when it is combined with Miocamycin"
                    },
                    {
                        "drugbank-id": "DB13338",
                        "description": "The serum concentration of Dihydroergocristine can be increased when it is combined with Flurithromycin"
                    },
                    {
                        "drugbank-id": "DB13409",
                        "description": "The serum concentration of Dihydroergocristine can be increased when it is combined with Rokitamycin"
                    },
                    {
                        "drugbank-id": "DB13456",
                        "description": "The serum concentration of Dihydroergocristine can be increased when it is combined with Midecamycin"
                    },
                    {
                        "drugbank-id": "DB00877",
                        "description": "The serum concentration of Sirolimus can be increased when it is combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB01590",
                        "description": "The serum concentration of Everolimus can be increased when it is combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB06287",
                        "description": "The serum concentration of Temsirolimus can be increased when it is combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB01190",
                        "description": "The serum concentration of Dihydroergocristine can be increased when it is combined with Clindamycin"
                    },
                    {
                        "drugbank-id": "DB13633",
                        "description": "The serum concentration of Dihydroergocristine can be increased when it is combined with Mepartricin"
                    },
                    {
                        "drugbank-id": "DB11642",
                        "description": "The serum concentration of Dihydroergocristine can be decreased when it is combined with Pitolisant"
                    },
                    {
                        "drugbank-id": "DB13967",
                        "description": "The therapeutic efficacy of Dihydroergocristine can be decreased when used in combination with Patent Blue"
                    },
                    {
                        "drugbank-id": "DB03619",
                        "description": "Deoxycholic acid may increase the excretion rate of Dihydroergocristine which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB04348",
                        "description": "Taurocholic acid may increase the excretion rate of Dihydroergocristine which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00175",
                        "description": "Pravastatin may decrease the excretion rate of Dihydroergocristine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00222",
                        "description": "Glimepiride may decrease the excretion rate of Dihydroergocristine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00243",
                        "description": "Ranolazine may decrease the excretion rate of Dihydroergocristine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00328",
                        "description": "Indomethacin may decrease the excretion rate of Dihydroergocristine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00421",
                        "description": "Spironolactone may decrease the excretion rate of Dihydroergocristine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00572",
                        "description": "Atropine may decrease the excretion rate of Dihydroergocristine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00693",
                        "description": "Fluorescein may decrease the excretion rate of Dihydroergocristine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00698",
                        "description": "Nitrofurantoin may decrease the excretion rate of Dihydroergocristine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00788",
                        "description": "Naproxen may decrease the excretion rate of Dihydroergocristine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00833",
                        "description": "Cefaclor may decrease the excretion rate of Dihydroergocristine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00966",
                        "description": "Telmisartan may decrease the excretion rate of Dihydroergocristine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00975",
                        "description": "Dipyridamole may decrease the excretion rate of Dihydroergocristine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01067",
                        "description": "Glipizide may decrease the excretion rate of Dihydroergocristine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01165",
                        "description": "Ofloxacin may decrease the excretion rate of Dihydroergocristine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB05804",
                        "description": "Prasterone sulfate may decrease the excretion rate of Dihydroergocristine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08860",
                        "description": "Pitavastatin may decrease the excretion rate of Dihydroergocristine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09374",
                        "description": "Indocyanine green acid form may decrease the excretion rate of Dihydroergocristine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB12319",
                        "description": "Benzbromarone may decrease the excretion rate of Dihydroergocristine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB12712",
                        "description": "Pilsicainide may decrease the excretion rate of Dihydroergocristine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13751",
                        "description": "Dihydroergocristine may decrease the excretion rate of Glycyrrhizic acid which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00973",
                        "description": "Ezetimibe may decrease the excretion rate of Dihydroergocristine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB02123",
                        "description": "Glycochenodeoxycholic Acid may decrease the excretion rate of Dihydroergocristine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01054",
                        "description": "Dihydroergocristine may decrease the excretion rate of Nitrendipine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00220",
                        "description": "Nelfinavir may decrease the excretion rate of Dihydroergocristine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00412",
                        "description": "Rosiglitazone may decrease the excretion rate of Dihydroergocristine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00455",
                        "description": "Loratadine may decrease the excretion rate of Dihydroergocristine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00586",
                        "description": "Diclofenac may decrease the excretion rate of Dihydroergocristine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00822",
                        "description": "Disulfiram may decrease the excretion rate of Dihydroergocristine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00911",
                        "description": "Tinidazole may decrease the excretion rate of Dihydroergocristine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00912",
                        "description": "Repaglinide may decrease the excretion rate of Dihydroergocristine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01076",
                        "description": "Atorvastatin may decrease the excretion rate of Dihydroergocristine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00641",
                        "description": "Simvastatin may decrease the excretion rate of Dihydroergocristine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01023",
                        "description": "Dihydroergocristine may decrease the excretion rate of Felodipine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00224",
                        "description": "Indinavir may decrease the excretion rate of Dihydroergocristine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB15719",
                        "description": "Dihydroergocristine may decrease the excretion rate of Belantamab mafodotin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00390",
                        "description": "Dihydroergocristine may decrease the excretion rate of Digoxin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00637",
                        "description": "Astemizole may decrease the excretion rate of Dihydroergocristine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00694",
                        "description": "Daunorubicin may decrease the excretion rate of Dihydroergocristine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09046",
                        "description": "The metabolism of Dihydroergocristine can be increased when combined with Metreleptin"
                    },
                    {
                        "drugbank-id": "DB00615",
                        "description": "The metabolism of Dihydroergocristine can be increased when combined with Rifabutin"
                    },
                    {
                        "drugbank-id": "DB00949",
                        "description": "The metabolism of Dihydroergocristine can be increased when combined with Felbamate"
                    },
                    {
                        "drugbank-id": "DB01645",
                        "description": "The metabolism of Dihydroergocristine can be increased when combined with Genistein"
                    },
                    {
                        "drugbank-id": "DB04911",
                        "description": "The metabolism of Dihydroergocristine can be increased when combined with Oritavancin"
                    },
                    {
                        "drugbank-id": "DB06201",
                        "description": "The metabolism of Dihydroergocristine can be increased when combined with Rufinamide"
                    },
                    {
                        "drugbank-id": "DB06413",
                        "description": "The metabolism of Dihydroergocristine can be increased when combined with Armodafinil"
                    },
                    {
                        "drugbank-id": "DB08909",
                        "description": "The metabolism of Dihydroergocristine can be increased when combined with Glycerol phenylbutyrate"
                    },
                    {
                        "drugbank-id": "DB09119",
                        "description": "The metabolism of Dihydroergocristine can be increased when combined with Eslicarbazepine acetate"
                    },
                    {
                        "drugbank-id": "DB11586",
                        "description": "The metabolism of Dihydroergocristine can be increased when combined with Asunaprevir"
                    },
                    {
                        "drugbank-id": "DB11767",
                        "description": "The metabolism of Dihydroergocristine can be increased when combined with Sarilumab"
                    },
                    {
                        "drugbank-id": "DB11560",
                        "description": "The metabolism of Dihydroergocristine can be increased when combined with Lesinurad"
                    },
                    {
                        "drugbank-id": "DB00082",
                        "description": "The metabolism of Dihydroergocristine can be increased when combined with Pegvisomant"
                    },
                    {
                        "drugbank-id": "DB00136",
                        "description": "The metabolism of Dihydroergocristine can be increased when combined with Calcitriol"
                    },
                    {
                        "drugbank-id": "DB00180",
                        "description": "The metabolism of Dihydroergocristine can be increased when combined with Flunisolide"
                    },
                    {
                        "drugbank-id": "DB00241",
                        "description": "The metabolism of Dihydroergocristine can be increased when combined with Butalbital"
                    },
                    {
                        "drugbank-id": "DB00301",
                        "description": "The metabolism of Dihydroergocristine can be increased when combined with Flucloxacillin"
                    },
                    {
                        "drugbank-id": "DB00316",
                        "description": "The metabolism of Dihydroergocristine can be increased when combined with Acetaminophen"
                    },
                    {
                        "drugbank-id": "DB00338",
                        "description": "The metabolism of Dihydroergocristine can be increased when combined with Omeprazole"
                    },
                    {
                        "drugbank-id": "DB00357",
                        "description": "The metabolism of Dihydroergocristine can be increased when combined with Aminoglutethimide"
                    },
                    {
                        "drugbank-id": "DB00394",
                        "description": "The metabolism of Dihydroergocristine can be increased when combined with Beclomethasone dipropionate"
                    },
                    {
                        "drugbank-id": "DB00400",
                        "description": "The metabolism of Dihydroergocristine can be increased when combined with Griseofulvin"
                    },
                    {
                        "drugbank-id": "DB00418",
                        "description": "The metabolism of Dihydroergocristine can be increased when combined with Secobarbital"
                    },
                    {
                        "drugbank-id": "DB00439",
                        "description": "The metabolism of Dihydroergocristine can be increased when combined with Cerivastatin"
                    },
                    {
                        "drugbank-id": "DB00443",
                        "description": "The metabolism of Dihydroergocristine can be increased when combined with Betamethasone"
                    },
                    {
                        "drugbank-id": "DB00448",
                        "description": "The metabolism of Dihydroergocristine can be increased when combined with Lansoprazole"
                    },
                    {
                        "drugbank-id": "DB00468",
                        "description": "The metabolism of Dihydroergocristine can be increased when combined with Quinine"
                    },
                    {
                        "drugbank-id": "DB00474",
                        "description": "The metabolism of Dihydroergocristine can be increased when combined with Methohexital"
                    },
                    {
                        "drugbank-id": "DB00485",
                        "description": "The metabolism of Dihydroergocristine can be increased when combined with Dicloxacillin"
                    },
                    {
                        "drugbank-id": "DB00533",
                        "description": "The metabolism of Dihydroergocristine can be increased when combined with Rofecoxib"
                    },
                    {
                        "drugbank-id": "DB00591",
                        "description": "The metabolism of Dihydroergocristine can be increased when combined with Fluocinolone acetonide"
                    },
                    {
                        "drugbank-id": "DB00599",
                        "description": "The metabolism of Dihydroergocristine can be increased when combined with Thiopental"
                    },
                    {
                        "drugbank-id": "DB00603",
                        "description": "The metabolism of Dihydroergocristine can be increased when combined with Medroxyprogesterone acetate"
                    },
                    {
                        "drugbank-id": "DB00620",
                        "description": "The metabolism of Dihydroergocristine can be increased when combined with Triamcinolone"
                    },
                    {
                        "drugbank-id": "DB00624",
                        "description": "The metabolism of Dihydroergocristine can be increased when combined with Testosterone"
                    },
                    {
                        "drugbank-id": "DB00636",
                        "description": "The metabolism of Dihydroergocristine can be increased when combined with Clofibrate"
                    },
                    {
                        "drugbank-id": "DB00741",
                        "description": "The metabolism of Dihydroergocristine can be increased when combined with Hydrocortisone"
                    },
                    {
                        "drugbank-id": "DB00754",
                        "description": "The metabolism of Dihydroergocristine can be increased when combined with Ethotoin"
                    },
                    {
                        "drugbank-id": "DB00769",
                        "description": "The metabolism of Dihydroergocristine can be increased when combined with Hydrocortamate"
                    },
                    {
                        "drugbank-id": "DB00812",
                        "description": "The metabolism of Dihydroergocristine can be increased when combined with Phenylbutazone"
                    },
                    {
                        "drugbank-id": "DB00849",
                        "description": "The metabolism of Dihydroergocristine can be increased when combined with Methylphenobarbital"
                    },
                    {
                        "drugbank-id": "DB00857",
                        "description": "The metabolism of Dihydroergocristine can be increased when combined with Terbinafine"
                    },
                    {
                        "drugbank-id": "DB00860",
                        "description": "The metabolism of Dihydroergocristine can be increased when combined with Prednisolone"
                    },
                    {
                        "drugbank-id": "DB00898",
                        "description": "The metabolism of Dihydroergocristine can be increased when combined with Ethanol"
                    },
                    {
                        "drugbank-id": "DB00957",
                        "description": "The metabolism of Dihydroergocristine can be increased when combined with Norgestimate"
                    },
                    {
                        "drugbank-id": "DB00959",
                        "description": "The metabolism of Dihydroergocristine can be increased when combined with Methylprednisolone"
                    },
                    {
                        "drugbank-id": "DB01011",
                        "description": "The metabolism of Dihydroergocristine can be increased when combined with Metyrapone"
                    },
                    {
                        "drugbank-id": "DB01030",
                        "description": "The metabolism of Dihydroergocristine can be increased when combined with Topotecan"
                    },
                    {
                        "drugbank-id": "DB01032",
                        "description": "The metabolism of Dihydroergocristine can be increased when combined with Probenecid"
                    },
                    {
                        "drugbank-id": "DB01083",
                        "description": "The metabolism of Dihydroergocristine can be increased when combined with Orlistat"
                    },
                    {
                        "drugbank-id": "DB01138",
                        "description": "The metabolism of Dihydroergocristine can be increased when combined with Sulfinpyrazone"
                    },
                    {
                        "drugbank-id": "DB01154",
                        "description": "The metabolism of Dihydroergocristine can be increased when combined with Thiamylal"
                    },
                    {
                        "drugbank-id": "DB01201",
                        "description": "The metabolism of Dihydroergocristine can be increased when combined with Rifapentine"
                    },
                    {
                        "drugbank-id": "DB01221",
                        "description": "The metabolism of Dihydroergocristine can be increased when combined with Ketamine"
                    },
                    {
                        "drugbank-id": "DB01285",
                        "description": "The metabolism of Dihydroergocristine can be increased when combined with Corticotropin"
                    },
                    {
                        "drugbank-id": "DB01333",
                        "description": "The metabolism of Dihydroergocristine can be increased when combined with Cefradine"
                    },
                    {
                        "drugbank-id": "DB01351",
                        "description": "The metabolism of Dihydroergocristine can be increased when combined with Amobarbital"
                    },
                    {
                        "drugbank-id": "DB01352",
                        "description": "The metabolism of Dihydroergocristine can be increased when combined with Aprobarbital"
                    },
                    {
                        "drugbank-id": "DB01380",
                        "description": "The metabolism of Dihydroergocristine can be increased when combined with Cortisone acetate"
                    },
                    {
                        "drugbank-id": "DB01384",
                        "description": "The metabolism of Dihydroergocristine can be increased when combined with Paramethasone"
                    },
                    {
                        "drugbank-id": "DB01483",
                        "description": "The metabolism of Dihydroergocristine can be increased when combined with Barbital"
                    },
                    {
                        "drugbank-id": "DB01609",
                        "description": "The metabolism of Dihydroergocristine can be increased when combined with Deferasirox"
                    },
                    {
                        "drugbank-id": "DB04817",
                        "description": "The metabolism of Dihydroergocristine can be increased when combined with Metamizole"
                    },
                    {
                        "drugbank-id": "DB04905",
                        "description": "The metabolism of Dihydroergocristine can be increased when combined with Tesmilifene"
                    },
                    {
                        "drugbank-id": "DB04920",
                        "description": "The metabolism of Dihydroergocristine can be increased when combined with Clevidipine"
                    },
                    {
                        "drugbank-id": "DB06636",
                        "description": "The metabolism of Dihydroergocristine can be increased when combined with Isavuconazonium"
                    },
                    {
                        "drugbank-id": "DB06708",
                        "description": "The metabolism of Dihydroergocristine can be increased when combined with Lumefantrine"
                    },
                    {
                        "drugbank-id": "DB06739",
                        "description": "The metabolism of Dihydroergocristine can be increased when combined with Seratrodast"
                    },
                    {
                        "drugbank-id": "DB08883",
                        "description": "The metabolism of Dihydroergocristine can be increased when combined with Perampanel"
                    },
                    {
                        "drugbank-id": "DB08905",
                        "description": "The metabolism of Dihydroergocristine can be increased when combined with Formestane"
                    },
                    {
                        "drugbank-id": "DB08906",
                        "description": "The metabolism of Dihydroergocristine can be increased when combined with Fluticasone furoate"
                    },
                    {
                        "drugbank-id": "DB08911",
                        "description": "The metabolism of Dihydroergocristine can be increased when combined with Trametinib"
                    },
                    {
                        "drugbank-id": "DB08970",
                        "description": "The metabolism of Dihydroergocristine can be increased when combined with Fluprednidene"
                    },
                    {
                        "drugbank-id": "DB09001",
                        "description": "The metabolism of Dihydroergocristine can be increased when combined with Barbexaclone"
                    },
                    {
                        "drugbank-id": "DB09383",
                        "description": "The metabolism of Dihydroergocristine can be increased when combined with Meprednisone"
                    },
                    {
                        "drugbank-id": "DB11487",
                        "description": "The metabolism of Dihydroergocristine can be increased when combined with Dexamethasone isonicotinate"
                    },
                    {
                        "drugbank-id": "DB11921",
                        "description": "The metabolism of Dihydroergocristine can be increased when combined with Deflazacort"
                    },
                    {
                        "drugbank-id": "DB13003",
                        "description": "The metabolism of Dihydroergocristine can be increased when combined with Cortivazol"
                    },
                    {
                        "drugbank-id": "DB13208",
                        "description": "The metabolism of Dihydroergocristine can be increased when combined with Prednylidene"
                    },
                    {
                        "drugbank-id": "DB13843",
                        "description": "The metabolism of Dihydroergocristine can be increased when combined with Cloprednol"
                    },
                    {
                        "drugbank-id": "DB13867",
                        "description": "The metabolism of Dihydroergocristine can be increased when combined with Fluticasone"
                    },
                    {
                        "drugbank-id": "DB13943",
                        "description": "The metabolism of Dihydroergocristine can be increased when combined with Testosterone cypionate"
                    },
                    {
                        "drugbank-id": "DB13944",
                        "description": "The metabolism of Dihydroergocristine can be increased when combined with Testosterone enanthate"
                    },
                    {
                        "drugbank-id": "DB13952",
                        "description": "The metabolism of Dihydroergocristine can be increased when combined with Estradiol acetate"
                    },
                    {
                        "drugbank-id": "DB13953",
                        "description": "The metabolism of Dihydroergocristine can be increased when combined with Estradiol benzoate"
                    },
                    {
                        "drugbank-id": "DB13954",
                        "description": "The metabolism of Dihydroergocristine can be increased when combined with Estradiol cypionate"
                    },
                    {
                        "drugbank-id": "DB13955",
                        "description": "The metabolism of Dihydroergocristine can be increased when combined with Estradiol dienanthate"
                    },
                    {
                        "drugbank-id": "DB13956",
                        "description": "The metabolism of Dihydroergocristine can be increased when combined with Estradiol valerate"
                    },
                    {
                        "drugbank-id": "DB14512",
                        "description": "The metabolism of Dihydroergocristine can be increased when combined with Mometasone furoate"
                    },
                    {
                        "drugbank-id": "DB14539",
                        "description": "The metabolism of Dihydroergocristine can be increased when combined with Hydrocortisone acetate"
                    },
                    {
                        "drugbank-id": "DB14545",
                        "description": "The metabolism of Dihydroergocristine can be increased when combined with Hydrocortisone succinate"
                    },
                    {
                        "drugbank-id": "DB14631",
                        "description": "The metabolism of Dihydroergocristine can be increased when combined with Prednisolone phosphate"
                    },
                    {
                        "drugbank-id": "DB14633",
                        "description": "The metabolism of Dihydroergocristine can be increased when combined with Prednisolone hemisuccinate"
                    },
                    {
                        "drugbank-id": "DB14644",
                        "description": "The metabolism of Dihydroergocristine can be increased when combined with Methylprednisolone hemisuccinate"
                    },
                    {
                        "drugbank-id": "DB14646",
                        "description": "The metabolism of Dihydroergocristine can be increased when combined with Prednisone acetate"
                    },
                    {
                        "drugbank-id": "DB14652",
                        "description": "The metabolism of Dihydroergocristine can be increased when combined with Clocortolone acetate"
                    },
                    {
                        "drugbank-id": "DB14659",
                        "description": "The metabolism of Dihydroergocristine can be increased when combined with Melengestrol acetate"
                    },
                    {
                        "drugbank-id": "DB14669",
                        "description": "The metabolism of Dihydroergocristine can be increased when combined with Betamethasone phosphate"
                    },
                    {
                        "drugbank-id": "DB14681",
                        "description": "The metabolism of Dihydroergocristine can be increased when combined with Cortisone"
                    },
                    {
                        "drugbank-id": "DB00602",
                        "description": "The metabolism of Dihydroergocristine can be increased when combined with Ivermectin"
                    },
                    {
                        "drugbank-id": "DB01115",
                        "description": "The metabolism of Dihydroergocristine can be increased when combined with Nifedipine"
                    },
                    {
                        "drugbank-id": "DB00349",
                        "description": "The metabolism of Dihydroergocristine can be increased when combined with Clobazam"
                    },
                    {
                        "drugbank-id": "DB00163",
                        "description": "The metabolism of Dihydroergocristine can be increased when combined with Vitamin E"
                    },
                    {
                        "drugbank-id": "DB00273",
                        "description": "The metabolism of Dihydroergocristine can be increased when combined with Topiramate"
                    },
                    {
                        "drugbank-id": "DB00776",
                        "description": "The metabolism of Dihydroergocristine can be increased when combined with Oxcarbazepine"
                    },
                    {
                        "drugbank-id": "DB14575",
                        "description": "The metabolism of Dihydroergocristine can be increased when combined with Eslicarbazepine"
                    },
                    {
                        "drugbank-id": "DB01222",
                        "description": "The metabolism of Dihydroergocristine can be increased when combined with Budesonide"
                    },
                    {
                        "drugbank-id": "DB01394",
                        "description": "The metabolism of Dihydroergocristine can be increased when combined with Colchicine"
                    },
                    {
                        "drugbank-id": "DB06717",
                        "description": "The metabolism of Dihydroergocristine can be increased when combined with Fosaprepitant"
                    },
                    {
                        "drugbank-id": "DB00454",
                        "description": "The metabolism of Dihydroergocristine can be increased when combined with Meperidine"
                    },
                    {
                        "drugbank-id": "DB01013",
                        "description": "The metabolism of Dihydroergocristine can be increased when combined with Clobetasol propionate"
                    },
                    {
                        "drugbank-id": "DB01047",
                        "description": "The metabolism of Dihydroergocristine can be increased when combined with Fluocinonide"
                    },
                    {
                        "drugbank-id": "DB14540",
                        "description": "The metabolism of Dihydroergocristine can be increased when combined with Hydrocortisone butyrate"
                    },
                    {
                        "drugbank-id": "DB00764",
                        "description": "The metabolism of Dihydroergocristine can be increased when combined with Mometasone"
                    },
                    {
                        "drugbank-id": "DB08971",
                        "description": "The metabolism of Dihydroergocristine can be increased when combined with Fluocortolone"
                    },
                    {
                        "drugbank-id": "DB11750",
                        "description": "The metabolism of Dihydroergocristine can be increased when combined with Clobetasol"
                    },
                    {
                        "drugbank-id": "DB15566",
                        "description": "The metabolism of Dihydroergocristine can be increased when combined with Prednisolone acetate"
                    },
                    {
                        "drugbank-id": "DB09095",
                        "description": "The metabolism of Dihydroergocristine can be increased when combined with Difluocortolone"
                    },
                    {
                        "drugbank-id": "DB01369",
                        "description": "The metabolism of Dihydroergocristine can be decreased when combined with Quinupristin"
                    },
                    {
                        "drugbank-id": "DB01764",
                        "description": "The metabolism of Dihydroergocristine can be decreased when combined with Dalfopristin"
                    },
                    {
                        "drugbank-id": "DB04894",
                        "description": "The metabolism of Dihydroergocristine can be decreased when combined with Vapreotide"
                    },
                    {
                        "drugbank-id": "DB05928",
                        "description": "The metabolism of Dihydroergocristine can be decreased when combined with Dovitinib"
                    },
                    {
                        "drugbank-id": "DB06663",
                        "description": "The metabolism of Dihydroergocristine can be decreased when combined with Pasireotide"
                    },
                    {
                        "drugbank-id": "DB06791",
                        "description": "The metabolism of Dihydroergocristine can be decreased when combined with Lanreotide"
                    },
                    {
                        "drugbank-id": "DB09099",
                        "description": "The metabolism of Dihydroergocristine can be decreased when combined with Somatostatin"
                    },
                    {
                        "drugbank-id": "DB00215",
                        "description": "The metabolism of Dihydroergocristine can be decreased when combined with Citalopram"
                    },
                    {
                        "drugbank-id": "DB00370",
                        "description": "The metabolism of Dihydroergocristine can be decreased when combined with Mirtazapine"
                    },
                    {
                        "drugbank-id": "DB00921",
                        "description": "The metabolism of Dihydroergocristine can be decreased when combined with Buprenorphine"
                    },
                    {
                        "drugbank-id": "DB01173",
                        "description": "The metabolism of Dihydroergocristine can be decreased when combined with Orphenadrine"
                    },
                    {
                        "drugbank-id": "DB01259",
                        "description": "The metabolism of Dihydroergocristine can be decreased when combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB04839",
                        "description": "The metabolism of Dihydroergocristine can be decreased when combined with Cyproterone acetate"
                    },
                    {
                        "drugbank-id": "DB04884",
                        "description": "The metabolism of Dihydroergocristine can be decreased when combined with Dapoxetine"
                    },
                    {
                        "drugbank-id": "DB08820",
                        "description": "The metabolism of Dihydroergocristine can be decreased when combined with Ivacaftor"
                    },
                    {
                        "drugbank-id": "DB09238",
                        "description": "The metabolism of Dihydroergocristine can be decreased when combined with Manidipine"
                    },
                    {
                        "drugbank-id": "DB12332",
                        "description": "The metabolism of Dihydroergocristine can be decreased when combined with Rucaparib"
                    },
                    {
                        "drugbank-id": "DB13941",
                        "description": "The metabolism of Piperaquine can be decreased when combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB13879",
                        "description": "The metabolism of Dihydroergocristine can be decreased when combined with Glecaprevir"
                    },
                    {
                        "drugbank-id": "DB11837",
                        "description": "The metabolism of Dihydroergocristine can be decreased when combined with Osilodrostat"
                    },
                    {
                        "drugbank-id": "DB08864",
                        "description": "The metabolism of Dihydroergocristine can be decreased when combined with Rilpivirine"
                    },
                    {
                        "drugbank-id": "DB04794",
                        "description": "The metabolism of Dihydroergocristine can be decreased when combined with Bifonazole"
                    },
                    {
                        "drugbank-id": "DB09241",
                        "description": "The metabolism of Dihydroergocristine can be decreased when combined with Methylene blue"
                    },
                    {
                        "drugbank-id": "DB00041",
                        "description": "The metabolism of Dihydroergocristine can be decreased when combined with Aldesleukin"
                    },
                    {
                        "drugbank-id": "DB00254",
                        "description": "The metabolism of Dihydroergocristine can be decreased when combined with Doxycycline"
                    },
                    {
                        "drugbank-id": "DB00255",
                        "description": "The metabolism of Dihydroergocristine can be decreased when combined with Diethylstilbestrol"
                    },
                    {
                        "drugbank-id": "DB00313",
                        "description": "The metabolism of Dihydroergocristine can be decreased when combined with Valproic acid"
                    },
                    {
                        "drugbank-id": "DB00317",
                        "description": "The metabolism of Dihydroergocristine can be decreased when combined with Gefitinib"
                    },
                    {
                        "drugbank-id": "DB00353",
                        "description": "The metabolism of Dihydroergocristine can be decreased when combined with Methylergometrine"
                    },
                    {
                        "drugbank-id": "DB00358",
                        "description": "The metabolism of Dihydroergocristine can be decreased when combined with Mefloquine"
                    },
                    {
                        "drugbank-id": "DB00435",
                        "description": "The metabolism of Dihydroergocristine can be decreased when combined with Nitric Oxide"
                    },
                    {
                        "drugbank-id": "DB00446",
                        "description": "The metabolism of Dihydroergocristine can be decreased when combined with Chloramphenicol"
                    },
                    {
                        "drugbank-id": "DB00481",
                        "description": "The metabolism of Dihydroergocristine can be decreased when combined with Raloxifene"
                    },
                    {
                        "drugbank-id": "DB00549",
                        "description": "The metabolism of Dihydroergocristine can be decreased when combined with Zafirlukast"
                    },
                    {
                        "drugbank-id": "DB00588",
                        "description": "The metabolism of Dihydroergocristine can be decreased when combined with Fluticasone propionate"
                    },
                    {
                        "drugbank-id": "DB00627",
                        "description": "The metabolism of Dihydroergocristine can be decreased when combined with Niacin"
                    },
                    {
                        "drugbank-id": "DB00647",
                        "description": "The metabolism of Dihydroergocristine can be decreased when combined with Dextropropoxyphene"
                    },
                    {
                        "drugbank-id": "DB00678",
                        "description": "The metabolism of Dihydroergocristine can be decreased when combined with Losartan"
                    },
                    {
                        "drugbank-id": "DB00681",
                        "description": "The metabolism of Dihydroergocristine can be decreased when combined with Amphotericin B"
                    },
                    {
                        "drugbank-id": "DB00715",
                        "description": "The metabolism of Dihydroergocristine can be decreased when combined with Paroxetine"
                    },
                    {
                        "drugbank-id": "DB00752",
                        "description": "The metabolism of Dihydroergocristine can be decreased when combined with Tranylcypromine"
                    },
                    {
                        "drugbank-id": "DB00759",
                        "description": "The metabolism of Dihydroergocristine can be decreased when combined with Tetracycline"
                    },
                    {
                        "drugbank-id": "DB00780",
                        "description": "The metabolism of Dihydroergocristine can be decreased when combined with Phenelzine"
                    },
                    {
                        "drugbank-id": "DB00819",
                        "description": "The metabolism of Dihydroergocristine can be decreased when combined with Acetazolamide"
                    },
                    {
                        "drugbank-id": "DB00829",
                        "description": "The metabolism of Dihydroergocristine can be decreased when combined with Diazepam"
                    },
                    {
                        "drugbank-id": "DB00916",
                        "description": "The metabolism of Dihydroergocristine can be decreased when combined with Metronidazole"
                    },
                    {
                        "drugbank-id": "DB01015",
                        "description": "The metabolism of Dihydroergocristine can be decreased when combined with Sulfamethoxazole"
                    },
                    {
                        "drugbank-id": "DB01029",
                        "description": "The metabolism of Dihydroergocristine can be decreased when combined with Irbesartan"
                    },
                    {
                        "drugbank-id": "DB01059",
                        "description": "The metabolism of Dihydroergocristine can be decreased when combined with Norfloxacin"
                    },
                    {
                        "drugbank-id": "DB01062",
                        "description": "The metabolism of Dihydroergocristine can be decreased when combined with Oxybutynin"
                    },
                    {
                        "drugbank-id": "DB01071",
                        "description": "The metabolism of Dihydroergocristine can be decreased when combined with Mequitazine"
                    },
                    {
                        "drugbank-id": "DB01085",
                        "description": "The metabolism of Dihydroergocristine can be decreased when combined with Pilocarpine"
                    },
                    {
                        "drugbank-id": "DB01129",
                        "description": "The metabolism of Dihydroergocristine can be decreased when combined with Rabeprazole"
                    },
                    {
                        "drugbank-id": "DB01151",
                        "description": "The metabolism of Dihydroergocristine can be decreased when combined with Desipramine"
                    },
                    {
                        "drugbank-id": "DB01204",
                        "description": "The metabolism of Dihydroergocristine can be decreased when combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB01275",
                        "description": "The metabolism of Dihydroergocristine can be decreased when combined with Hydralazine"
                    },
                    {
                        "drugbank-id": "DB01388",
                        "description": "The metabolism of Dihydroergocristine can be decreased when combined with Mibefradil"
                    },
                    {
                        "drugbank-id": "DB01587",
                        "description": "The metabolism of Dihydroergocristine can be decreased when combined with Ketazolam"
                    },
                    {
                        "drugbank-id": "DB01628",
                        "description": "The metabolism of Dihydroergocristine can be decreased when combined with Etoricoxib"
                    },
                    {
                        "drugbank-id": "DB01685",
                        "description": "The metabolism of Dihydroergocristine can be decreased when combined with Topiroxostat"
                    },
                    {
                        "drugbank-id": "DB01698",
                        "description": "The metabolism of Dihydroergocristine can be decreased when combined with Rutin"
                    },
                    {
                        "drugbank-id": "DB02709",
                        "description": "The metabolism of Dihydroergocristine can be decreased when combined with Resveratrol"
                    },
                    {
                        "drugbank-id": "DB05482",
                        "description": "The metabolism of Dihydroergocristine can be decreased when combined with 7 ethyl 10 hydroxycamptothecin"
                    },
                    {
                        "drugbank-id": "DB05814",
                        "description": "The metabolism of Dihydroergocristine can be decreased when combined with GPI 1485"
                    },
                    {
                        "drugbank-id": "DB06174",
                        "description": "The metabolism of Dihydroergocristine can be decreased when combined with Noscapine"
                    },
                    {
                        "drugbank-id": "DB06268",
                        "description": "The metabolism of Dihydroergocristine can be decreased when combined with Sitaxentan"
                    },
                    {
                        "drugbank-id": "DB06370",
                        "description": "The metabolism of Dihydroergocristine can be decreased when combined with Indisulam"
                    },
                    {
                        "drugbank-id": "DB06412",
                        "description": "The metabolism of Dihydroergocristine can be decreased when combined with Oxymetholone"
                    },
                    {
                        "drugbank-id": "DB06458",
                        "description": "The metabolism of Dihydroergocristine can be decreased when combined with Remacemide"
                    },
                    {
                        "drugbank-id": "DB06469",
                        "description": "The metabolism of Dihydroergocristine can be decreased when combined with Lestaurtinib"
                    },
                    {
                        "drugbank-id": "DB06774",
                        "description": "The metabolism of Dihydroergocristine can be decreased when combined with Capsaicin"
                    },
                    {
                        "drugbank-id": "DB08811",
                        "description": "The metabolism of Dihydroergocristine can be decreased when combined with Tofisopam"
                    },
                    {
                        "drugbank-id": "DB09235",
                        "description": "The metabolism of Dihydroergocristine can be decreased when combined with Efonidipine"
                    },
                    {
                        "drugbank-id": "DB11198",
                        "description": "The metabolism of Dihydroergocristine can be decreased when combined with Peppermint oil"
                    },
                    {
                        "drugbank-id": "DB11574",
                        "description": "The metabolism of Dihydroergocristine can be decreased when combined with Elbasvir"
                    },
                    {
                        "drugbank-id": "DB11805",
                        "description": "The metabolism of Dihydroergocristine can be decreased when combined with Saracatinib"
                    },
                    {
                        "drugbank-id": "DB12010",
                        "description": "The metabolism of Dihydroergocristine can be decreased when combined with Fostamatinib"
                    },
                    {
                        "drugbank-id": "DB12245",
                        "description": "The metabolism of Dihydroergocristine can be decreased when combined with Triclabendazole"
                    },
                    {
                        "drugbank-id": "DB12532",
                        "description": "The metabolism of Dihydroergocristine can be decreased when combined with Oxetacaine"
                    },
                    {
                        "drugbank-id": "DB13950",
                        "description": "The metabolism of Dihydroergocristine can be decreased when combined with WIN 55212 2"
                    },
                    {
                        "drugbank-id": "DB13975",
                        "description": "The metabolism of Dihydroergocristine can be decreased when combined with Black cohosh"
                    },
                    {
                        "drugbank-id": "DB14009",
                        "description": "The metabolism of Medical Cannabis can be decreased when combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB00333",
                        "description": "The metabolism of Dihydroergocristine can be decreased when combined with Methadone"
                    },
                    {
                        "drugbank-id": "DB01095",
                        "description": "The metabolism of Dihydroergocristine can be decreased when combined with Fluvastatin"
                    },
                    {
                        "drugbank-id": "DB01093",
                        "description": "The metabolism of Dihydroergocristine can be decreased when combined with Dimethyl sulfoxide"
                    },
                    {
                        "drugbank-id": "DB00701",
                        "description": "The metabolism of Dihydroergocristine can be decreased when combined with Amprenavir"
                    },
                    {
                        "drugbank-id": "DB14635",
                        "description": "The metabolism of Dihydroergocristine can be decreased when combined with Curcumin sulfate"
                    },
                    {
                        "drugbank-id": "DB00683",
                        "description": "The metabolism of Dihydroergocristine can be decreased when combined with Midazolam"
                    },
                    {
                        "drugbank-id": "DB08816",
                        "description": "The metabolism of Dihydroergocristine can be decreased when combined with Ticagrelor"
                    },
                    {
                        "drugbank-id": "DB00845",
                        "description": "The metabolism of Dihydroergocristine can be decreased when combined with Clofazimine"
                    },
                    {
                        "drugbank-id": "DB00104",
                        "description": "The metabolism of Dihydroergocristine can be decreased when combined with Octreotide"
                    },
                    {
                        "drugbank-id": "DB00619",
                        "description": "The metabolism of Dihydroergocristine can be decreased when combined with Imatinib"
                    },
                    {
                        "drugbank-id": "DB00570",
                        "description": "The metabolism of Dihydroergocristine can be decreased when combined with Vinblastine"
                    },
                    {
                        "drugbank-id": "DB00675",
                        "description": "The metabolism of Dihydroergocristine can be decreased when combined with Tamoxifen"
                    },
                    {
                        "drugbank-id": "DB08912",
                        "description": "The metabolism of Dihydroergocristine can be decreased when combined with Dabrafenib"
                    },
                    {
                        "drugbank-id": "DB08865",
                        "description": "The metabolism of Dihydroergocristine can be decreased when combined with Crizotinib"
                    },
                    {
                        "drugbank-id": "DB11581",
                        "description": "The metabolism of Dihydroergocristine can be decreased when combined with Venetoclax"
                    },
                    {
                        "drugbank-id": "DB12015",
                        "description": "The metabolism of Dihydroergocristine can be decreased when combined with Alpelisib"
                    },
                    {
                        "drugbank-id": "DB00531",
                        "description": "The metabolism of Dihydroergocristine can be decreased when combined with Cyclophosphamide"
                    },
                    {
                        "drugbank-id": "DB00773",
                        "description": "The metabolism of Dihydroergocristine can be decreased when combined with Etoposide"
                    },
                    {
                        "drugbank-id": "DB01181",
                        "description": "The metabolism of Dihydroergocristine can be decreased when combined with Ifosfamide"
                    },
                    {
                        "drugbank-id": "DB08881",
                        "description": "The metabolism of Dihydroergocristine can be decreased when combined with Vemurafenib"
                    },
                    {
                        "drugbank-id": "DB09330",
                        "description": "The metabolism of Dihydroergocristine can be decreased when combined with Osimertinib"
                    },
                    {
                        "drugbank-id": "DB12267",
                        "description": "The metabolism of Dihydroergocristine can be decreased when combined with Brigatinib"
                    },
                    {
                        "drugbank-id": "DB13874",
                        "description": "The metabolism of Dihydroergocristine can be decreased when combined with Enasidenib"
                    },
                    {
                        "drugbank-id": "DB14568",
                        "description": "The metabolism of Dihydroergocristine can be decreased when combined with Ivosidenib"
                    },
                    {
                        "drugbank-id": "DB11703",
                        "description": "The metabolism of Dihydroergocristine can be decreased when combined with Acalabrutinib"
                    },
                    {
                        "drugbank-id": "DB00398",
                        "description": "The metabolism of Dihydroergocristine can be decreased when combined with Sorafenib"
                    },
                    {
                        "drugbank-id": "DB00444",
                        "description": "The metabolism of Dihydroergocristine can be decreased when combined with Teniposide"
                    },
                    {
                        "drugbank-id": "DB00530",
                        "description": "The metabolism of Dihydroergocristine can be decreased when combined with Erlotinib"
                    },
                    {
                        "drugbank-id": "DB00997",
                        "description": "The metabolism of Dihydroergocristine can be decreased when combined with Doxorubicin"
                    },
                    {
                        "drugbank-id": "DB01248",
                        "description": "The metabolism of Dihydroergocristine can be decreased when combined with Docetaxel"
                    },
                    {
                        "drugbank-id": "DB01268",
                        "description": "The metabolism of Dihydroergocristine can be decreased when combined with Sunitinib"
                    },
                    {
                        "drugbank-id": "DB05773",
                        "description": "The metabolism of Dihydroergocristine can be decreased when combined with Trastuzumab emtansine"
                    },
                    {
                        "drugbank-id": "DB06616",
                        "description": "The metabolism of Dihydroergocristine can be decreased when combined with Bosutinib"
                    },
                    {
                        "drugbank-id": "DB08870",
                        "description": "The metabolism of Dihydroergocristine can be decreased when combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB08896",
                        "description": "The metabolism of Dihydroergocristine can be decreased when combined with Regorafenib"
                    },
                    {
                        "drugbank-id": "DB00091",
                        "description": "The metabolism of Cyclosporine can be decreased when combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB00204",
                        "description": "The metabolism of Dofetilide can be decreased when combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB00277",
                        "description": "The metabolism of Theophylline can be decreased when combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB00682",
                        "description": "The metabolism of Warfarin can be decreased when combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB00864",
                        "description": "The metabolism of Tacrolimus can be decreased when combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB00908",
                        "description": "The metabolism of Quinidine can be decreased when combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB00946",
                        "description": "The metabolism of Phenprocoumon can be decreased when combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB01008",
                        "description": "The metabolism of Busulfan can be decreased when combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB01100",
                        "description": "The metabolism of Pimozide can be decreased when combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB01118",
                        "description": "The metabolism of Amiodarone can be decreased when combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB01223",
                        "description": "The metabolism of Aminophylline can be decreased when combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB01229",
                        "description": "The metabolism of Paclitaxel can be decreased when combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB01254",
                        "description": "The metabolism of Dasatinib can be decreased when combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB01396",
                        "description": "The metabolism of Digitoxin can be decreased when combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB01418",
                        "description": "The metabolism of Acenocoumarol can be decreased when combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB04855",
                        "description": "The metabolism of Dronedarone can be decreased when combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB09289",
                        "description": "The metabolism of Tianeptine can be decreased when combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB01128",
                        "description": "The metabolism of Dihydroergocristine can be decreased when combined with Bicalutamide"
                    },
                    {
                        "drugbank-id": "DB05239",
                        "description": "The metabolism of Dihydroergocristine can be decreased when combined with Cobimetinib"
                    },
                    {
                        "drugbank-id": "DB06589",
                        "description": "The metabolism of Dihydroergocristine can be decreased when combined with Pazopanib"
                    },
                    {
                        "drugbank-id": "DB09063",
                        "description": "The metabolism of Dihydroergocristine can be decreased when combined with Ceritinib"
                    },
                    {
                        "drugbank-id": "DB09073",
                        "description": "The metabolism of Dihydroergocristine can be decreased when combined with Palbociclib"
                    },
                    {
                        "drugbank-id": "DB09074",
                        "description": "The metabolism of Dihydroergocristine can be decreased when combined with Olaparib"
                    },
                    {
                        "drugbank-id": "DB11963",
                        "description": "The metabolism of Dihydroergocristine can be decreased when combined with Dacomitinib"
                    },
                    {
                        "drugbank-id": "DB00541",
                        "description": "The metabolism of Dihydroergocristine can be decreased when combined with Vincristine"
                    },
                    {
                        "drugbank-id": "DB12371",
                        "description": "The metabolism of Dihydroergocristine can be decreased when combined with Siponimod"
                    },
                    {
                        "drugbank-id": "DB00540",
                        "description": "The metabolism of Dihydroergocristine can be decreased when combined with Nortriptyline"
                    },
                    {
                        "drugbank-id": "DB01242",
                        "description": "The metabolism of Dihydroergocristine can be decreased when combined with Clomipramine"
                    },
                    {
                        "drugbank-id": "DB08827",
                        "description": "The metabolism of Dihydroergocristine can be decreased when combined with Lomitapide"
                    },
                    {
                        "drugbank-id": "DB00563",
                        "description": "The metabolism of Methotrexate can be decreased when combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB00361",
                        "description": "The metabolism of Vinorelbine can be decreased when combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB04572",
                        "description": "The metabolism of Thiotepa can be decreased when combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB05109",
                        "description": "The metabolism of Trabectedin can be decreased when combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB05294",
                        "description": "The metabolism of Vandetanib can be decreased when combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB11363",
                        "description": "The metabolism of Alectinib can be decreased when combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB11641",
                        "description": "The metabolism of Vinflunine can be decreased when combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB15035",
                        "description": "The metabolism of Zanubrutinib can be decreased when combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB00188",
                        "description": "The metabolism of Bortezomib can be decreased when combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB00309",
                        "description": "The metabolism of Vindesine can be decreased when combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB06603",
                        "description": "The metabolism of Panobinostat can be decreased when combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB06626",
                        "description": "The metabolism of Axitinib can be decreased when combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB08877",
                        "description": "The metabolism of Ruxolitinib can be decreased when combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB08901",
                        "description": "The metabolism of Ponatinib can be decreased when combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB09054",
                        "description": "The metabolism of Idelalisib can be decreased when combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB09143",
                        "description": "The metabolism of Sonidegib can be decreased when combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB09570",
                        "description": "The metabolism of Ixazomib can be decreased when combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB11828",
                        "description": "The metabolism of Neratinib can be decreased when combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB11986",
                        "description": "The metabolism of Entrectinib can be decreased when combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB12147",
                        "description": "The metabolism of Erdafitinib can be decreased when combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB12483",
                        "description": "The metabolism of Copanlisib can be decreased when combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB12978",
                        "description": "The metabolism of Pexidartinib can be decreased when combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB00762",
                        "description": "The metabolism of Irinotecan can be decreased when combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB06176",
                        "description": "The metabolism of Romidepsin can be decreased when combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB06212",
                        "description": "The metabolism of Tolvaptan can be decreased when combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB08910",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB11817",
                        "description": "The metabolism of Baricitinib can be decreased when combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB12001",
                        "description": "The metabolism of Abemaciclib can be decreased when combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB01227",
                        "description": "The metabolism of Levacetylmethadol can be decreased when combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB06772",
                        "description": "The metabolism of Cabazitaxel can be decreased when combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB01039",
                        "description": "The metabolism of Dihydroergocristine can be decreased when combined with Fenofibrate"
                    },
                    {
                        "drugbank-id": "DB01098",
                        "description": "The metabolism of Dihydroergocristine can be decreased when combined with Rosuvastatin"
                    },
                    {
                        "drugbank-id": "DB00186",
                        "description": "The metabolism of Dihydroergocristine can be decreased when combined with Lorazepam"
                    },
                    {
                        "drugbank-id": "DB00208",
                        "description": "The metabolism of Dihydroergocristine can be decreased when combined with Ticlopidine"
                    },
                    {
                        "drugbank-id": "DB00426",
                        "description": "The metabolism of Dihydroergocristine can be decreased when combined with Famciclovir"
                    },
                    {
                        "drugbank-id": "DB00433",
                        "description": "The metabolism of Dihydroergocristine can be decreased when combined with Prochlorperazine"
                    },
                    {
                        "drugbank-id": "DB00476",
                        "description": "The metabolism of Dihydroergocristine can be decreased when combined with Duloxetine"
                    },
                    {
                        "drugbank-id": "DB00518",
                        "description": "The metabolism of Dihydroergocristine can be decreased when combined with Albendazole"
                    },
                    {
                        "drugbank-id": "DB00567",
                        "description": "The metabolism of Dihydroergocristine can be decreased when combined with Cephalexin"
                    },
                    {
                        "drugbank-id": "DB00590",
                        "description": "The metabolism of Dihydroergocristine can be decreased when combined with Doxazosin"
                    },
                    {
                        "drugbank-id": "DB00717",
                        "description": "The metabolism of Dihydroergocristine can be decreased when combined with Norethisterone"
                    },
                    {
                        "drugbank-id": "DB01411",
                        "description": "The metabolism of Dihydroergocristine can be decreased when combined with Pranlukast"
                    },
                    {
                        "drugbank-id": "DB01431",
                        "description": "The metabolism of Dihydroergocristine can be decreased when combined with Allylestrenol"
                    },
                    {
                        "drugbank-id": "DB01624",
                        "description": "The metabolism of Dihydroergocristine can be decreased when combined with Zuclopenthixol"
                    },
                    {
                        "drugbank-id": "DB01656",
                        "description": "The metabolism of Dihydroergocristine can be decreased when combined with Roflumilast"
                    },
                    {
                        "drugbank-id": "DB06218",
                        "description": "The metabolism of Dihydroergocristine can be decreased when combined with Lacosamide"
                    },
                    {
                        "drugbank-id": "DB06480",
                        "description": "The metabolism of Dihydroergocristine can be decreased when combined with Prucalopride"
                    },
                    {
                        "drugbank-id": "DB09030",
                        "description": "The metabolism of Dihydroergocristine can be decreased when combined with Vorapaxar"
                    },
                    {
                        "drugbank-id": "DB09034",
                        "description": "The metabolism of Dihydroergocristine can be decreased when combined with Suvorexant"
                    },
                    {
                        "drugbank-id": "DB09071",
                        "description": "The metabolism of Dihydroergocristine can be decreased when combined with Tasimelteon"
                    },
                    {
                        "drugbank-id": "DB09079",
                        "description": "The metabolism of Dihydroergocristine can be decreased when combined with Nintedanib"
                    },
                    {
                        "drugbank-id": "DB09299",
                        "description": "The metabolism of Dihydroergocristine can be decreased when combined with Tenofovir alafenamide"
                    },
                    {
                        "drugbank-id": "DB11094",
                        "description": "The metabolism of Dihydroergocristine can be decreased when combined with Vitamin D"
                    },
                    {
                        "drugbank-id": "DB11952",
                        "description": "The metabolism of Dihydroergocristine can be decreased when combined with Duvelisib"
                    },
                    {
                        "drugbank-id": "DB12141",
                        "description": "The metabolism of Dihydroergocristine can be decreased when combined with Gilteritinib"
                    },
                    {
                        "drugbank-id": "DB12515",
                        "description": "The metabolism of Dihydroergocristine can be decreased when combined with 9 aminocamptothecin"
                    },
                    {
                        "drugbank-id": "DB12952",
                        "description": "The metabolism of Dihydroergocristine can be decreased when combined with Methylprednisone"
                    },
                    {
                        "drugbank-id": "DB13385",
                        "description": "The metabolism of Dihydroergocryptine can be decreased when combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB14126",
                        "description": "The metabolism of Tenofovir can be decreased when combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB01395",
                        "description": "The metabolism of Dihydroergocristine can be decreased when combined with Drospirenone"
                    },
                    {
                        "drugbank-id": "DB15444",
                        "description": "The metabolism of Elexacaftor can be decreased when combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB12825",
                        "description": "The metabolism of Dihydroergocristine can be decreased when combined with Lefamulin"
                    },
                    {
                        "drugbank-id": "DB12887",
                        "description": "The metabolism of Dihydroergocristine can be decreased when combined with Tazemetostat"
                    },
                    {
                        "drugbank-id": "DB00247",
                        "description": "The metabolism of Dihydroergocristine can be decreased when combined with Methysergide"
                    },
                    {
                        "drugbank-id": "DB11742",
                        "description": "The metabolism of Dihydroergocristine can be decreased when combined with Ebastine"
                    },
                    {
                        "drugbank-id": "DB00604",
                        "description": "The metabolism of Dihydroergocristine can be decreased when combined with Cisapride"
                    },
                    {
                        "drugbank-id": "DB12927",
                        "description": "The therapeutic efficacy of Theodrenaline can be decreased when used in combination with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB13917",
                        "description": "The therapeutic efficacy of Deoxyepinephrine can be decreased when used in combination with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB00005",
                        "description": "The metabolism of Dihydroergocristine can be increased when combined with Etanercept"
                    },
                    {
                        "drugbank-id": "DB00026",
                        "description": "The metabolism of Dihydroergocristine can be increased when combined with Anakinra"
                    },
                    {
                        "drugbank-id": "DB00051",
                        "description": "The metabolism of Dihydroergocristine can be increased when combined with Adalimumab"
                    },
                    {
                        "drugbank-id": "DB00065",
                        "description": "The metabolism of Dihydroergocristine can be increased when combined with Infliximab"
                    },
                    {
                        "drugbank-id": "DB01281",
                        "description": "The metabolism of Dihydroergocristine can be increased when combined with Abatacept"
                    },
                    {
                        "drugbank-id": "DB04956",
                        "description": "The metabolism of Dihydroergocristine can be increased when combined with Afelimomab"
                    },
                    {
                        "drugbank-id": "DB05676",
                        "description": "The metabolism of Dihydroergocristine can be increased when combined with Apremilast"
                    },
                    {
                        "drugbank-id": "DB06168",
                        "description": "The metabolism of Dihydroergocristine can be increased when combined with Canakinumab"
                    },
                    {
                        "drugbank-id": "DB06273",
                        "description": "The metabolism of Dihydroergocristine can be increased when combined with Tocilizumab"
                    },
                    {
                        "drugbank-id": "DB06372",
                        "description": "The metabolism of Dihydroergocristine can be increased when combined with Rilonacept"
                    },
                    {
                        "drugbank-id": "DB06674",
                        "description": "The metabolism of Dihydroergocristine can be increased when combined with Golimumab"
                    },
                    {
                        "drugbank-id": "DB08904",
                        "description": "The metabolism of Dihydroergocristine can be increased when combined with Certolizumab pegol"
                    },
                    {
                        "drugbank-id": "DB09029",
                        "description": "The metabolism of Dihydroergocristine can be increased when combined with Secukinumab"
                    },
                    {
                        "drugbank-id": "DB09036",
                        "description": "The metabolism of Dihydroergocristine can be increased when combined with Siltuximab"
                    },
                    {
                        "drugbank-id": "DB14724",
                        "description": "The metabolism of Dihydroergocristine can be increased when combined with Emapalumab"
                    },
                    {
                        "drugbank-id": "DB00182",
                        "description": "The therapeutic efficacy of Dihydroergocristine can be decreased when used in combination with Amphetamine"
                    },
                    {
                        "drugbank-id": "DB00191",
                        "description": "The therapeutic efficacy of Dihydroergocristine can be decreased when used in combination with Phentermine"
                    },
                    {
                        "drugbank-id": "DB00852",
                        "description": "The therapeutic efficacy of Dihydroergocristine can be decreased when used in combination with Pseudoephedrine"
                    },
                    {
                        "drugbank-id": "DB00865",
                        "description": "The therapeutic efficacy of Dihydroergocristine can be decreased when used in combination with Benzphetamine"
                    },
                    {
                        "drugbank-id": "DB00937",
                        "description": "The therapeutic efficacy of Dihydroergocristine can be decreased when used in combination with Diethylpropion"
                    },
                    {
                        "drugbank-id": "DB01255",
                        "description": "The therapeutic efficacy of Dihydroergocristine can be decreased when used in combination with Lisdexamfetamine"
                    },
                    {
                        "drugbank-id": "DB01365",
                        "description": "The therapeutic efficacy of Dihydroergocristine can be decreased when used in combination with Mephentermine"
                    },
                    {
                        "drugbank-id": "DB01442",
                        "description": "The therapeutic efficacy of Dihydroergocristine can be decreased when used in combination with MMDA"
                    },
                    {
                        "drugbank-id": "DB01454",
                        "description": "The therapeutic efficacy of Dihydroergocristine can be decreased when used in combination with Midomafetamine"
                    },
                    {
                        "drugbank-id": "DB01467",
                        "description": "The therapeutic efficacy of Dihydroergocristine can be decreased when used in combination with 2 5 Dimethoxy 4 ethylamphetamine"
                    },
                    {
                        "drugbank-id": "DB01484",
                        "description": "The therapeutic efficacy of Dihydroergocristine can be decreased when used in combination with 4 Bromo 2 5 dimethoxyamphetamine"
                    },
                    {
                        "drugbank-id": "DB01509",
                        "description": "The therapeutic efficacy of Dihydroergocristine can be decreased when used in combination with Tenamfetamine"
                    },
                    {
                        "drugbank-id": "DB01556",
                        "description": "The therapeutic efficacy of Dihydroergocristine can be decreased when used in combination with Chlorphentermine"
                    },
                    {
                        "drugbank-id": "DB01566",
                        "description": "The therapeutic efficacy of Dihydroergocristine can be decreased when used in combination with Methylenedioxyethamphetamine"
                    },
                    {
                        "drugbank-id": "DB01576",
                        "description": "The therapeutic efficacy of Dihydroergocristine can be decreased when used in combination with Dextroamphetamine"
                    },
                    {
                        "drugbank-id": "DB01577",
                        "description": "The therapeutic efficacy of Dihydroergocristine can be decreased when used in combination with Metamfetamine"
                    },
                    {
                        "drugbank-id": "DB09480",
                        "description": "The therapeutic efficacy of Dihydroergocristine can be decreased when used in combination with Iofetamine I 123"
                    },
                    {
                        "drugbank-id": "DB12080",
                        "description": "The therapeutic efficacy of Dihydroergocristine can be decreased when used in combination with Ritobegron"
                    },
                    {
                        "drugbank-id": "DB13108",
                        "description": "The therapeutic efficacy of Dihydroergocristine can be decreased when used in combination with Mephedrone"
                    },
                    {
                        "drugbank-id": "DB13624",
                        "description": "The therapeutic efficacy of Dihydroergocristine can be decreased when used in combination with Methoxyphenamine"
                    },
                    {
                        "drugbank-id": "DB13703",
                        "description": "The therapeutic efficacy of Dihydroergocristine can be decreased when used in combination with Gepefrine"
                    },
                    {
                        "drugbank-id": "DB13940",
                        "description": "The therapeutic efficacy of Dihydroergocristine can be decreased when used in combination with 2 5 Dimethoxy 4 ethylthioamphetamine"
                    },
                    {
                        "drugbank-id": "DB00199",
                        "description": "Erythromycin may increase the vasoconstricting activities of Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB00778",
                        "description": "Roxithromycin may increase the vasoconstricting activities of Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB00976",
                        "description": "Telithromycin may increase the vasoconstricting activities of Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB06419",
                        "description": "Cethromycin may increase the vasoconstricting activities of Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB11823",
                        "description": "The risk or severity of hypertension can be increased when Esketamine is combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB14754",
                        "description": "The risk or severity of hypertension can be increased when Solriamfetol is combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB13946",
                        "description": "Testosterone undecanoate may increase the hypertensive activities of Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB00281",
                        "description": "The risk or severity of hypertension can be increased when Dihydroergocristine is combined with Lidocaine"
                    },
                    {
                        "drugbank-id": "DB06119",
                        "description": "The serum concentration of Dihydroergocristine can be decreased when it is combined with Cenobamate"
                    },
                    {
                        "drugbank-id": "DB01020",
                        "description": "Dihydroergocristine may increase the vasodilatory activities of Isosorbide mononitrate"
                    },
                    {
                        "drugbank-id": "DB01601",
                        "description": "The serum concentration of Lopinavir can be increased when it is combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB00503",
                        "description": "The serum concentration of Dihydroergocristine can be increased when it is combined with Ritonavir"
                    },
                    {
                        "drugbank-id": "DB00502",
                        "description": "The serum concentration of Dihydroergocristine can be increased when it is combined with Haloperidol"
                    },
                    {
                        "drugbank-id": "DB11652",
                        "description": "The metabolism of Tucatinib can be decreased when combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB11932",
                        "description": "The serum concentration of Dihydroergocristine can be increased when it is combined with Abametapir"
                    },
                    {
                        "drugbank-id": "DB15762",
                        "description": "The serum concentration of Dihydroergocristine can be decreased when it is combined with Satralizumab"
                    }
                ]
            }
        },
        "revision_date": "2023-05-14"
    }
}